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Xerostomia is a common clinical symptom that may suffer patients with Head and Neck 
Cancers during and after radiotherapy. The aim of the present thesis were therefore: 1) 
to review the current state of knowledge of pathology, clinical complications and 
radiotherapeutic patient management, 2) to evaluate the aetiology of dentine 
hypersensitivity in conditions of reduced salivary flow resulting in the radiation 
exposure, 3) to evaluate the effectiveness of the materials commonly used in the 
treatment of hypersensitivity, when they work in conditions of hyposalivation. 
Paper I is systematic review of actual management strategies for radiation-induced 
hypofunction and xerostomia in head and neck cancer patients. Paper II and III are 
based on the data of two split-mouth randomized clinical trial, where the efficacy of 4 
different kinds of desensitizers has been assessed in the short and long term on patients 
with normal salivary flow. Paper IV is a long term evaluation based on the same 
experimental protocol applied on xerostomic patients. 
The results showed that Dentine hypersensitivity is one among the multiple 
complications in the oral cavity that is possible diagnose in patients affected by 
xerostomia post radiotherapy. It may occur as a result of the combination between the 
typical etiologic factors and the reduction in salivary flow, that have a essential 
protective role for teeth and oral mucosa health. Dentine hypersensitivity arise from the 
tubular dentine exposure as a result of enamel loss and/or gingival root surface exposure 
and their occlusion is the first choice for the treatment. Unfortunately, there is still no 
gold standard for therapy of DH available today. In addiction, there is in the literature a 
lack of information about DH in xerostomic patients after radiotherapy. 
The main conclusions from this thesis are that: 1) the radiation-induced xerostomia 
could be considered a multifactorial disease. It could depend on the type of cancer 
treatment and the cumulative radiation dose to the gland tissue. A preventive approach 
and the correct treatment of the particular radiotherapeutic patient can help to improve 
the condition of xerostomia. 2)The experimental data obtained from patients with 
normal salivary flow show that all the materials tested produced a reduction of dentine 
permeability. However, after 12-week controls, there was no significant statistical 
difference in the efficacy. 3) In xerostomic condition all the materials tested produced a 
significant reduction in the dentine sensibility. In light of the observed data, after 12-
week controls there is no statistically significant difference between the desensitizers 
and they show a less stable behaviour compared to the normal salivation condition. 
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This thesis is based on the following four papers, which will be referred to in the text by 
their Roman numerals: 
 
I. Xerostomia induced by radiotherapy: an overview of the physio-pathology, 
clinical evidence and management of the oral damage. 
 Pinna R, Campus G, Cumbo E, Mura I, Milia E. 
 Ther Clin Risk Manag. 2015;11. 
 
II. Short-term response of three resin-based materials as desensitizing agents 
under oral environmental exposure. 
Milia E, Castelli G, Bortone A, Sotgiu G, Manunta A, Pinna R, Gallina G. 
Acta Odontol Scand 2013;71:599-609. 
 
III. Clinical evaluation of the efficacy of one self-adhesive composite in dental 
hypersensitivity. 
Pinna R, Bortone A, Sotgiu G, Dore S, Usai P, Milia E. 
Clin Oral Investig. 2014; In press. 
 
IV. Clinical evaluation of a self-adhering material as desensitizing agent in 
xerostomic patients for head and neck cancer. 
 Pinna R, Dore S, Sotgiu G, Milia E. 
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Xerostomia induced by radiotherapy in head and neck cancers. 
Xerostomia is a term used to describe the subjective symptoms of a dry mouth often 
deriving from a lack of saliva. A large variety of causes can lead to xerostomia e.g. 
radiotherapy and chemotherapy(1-4), the chronic use of drugs (5-7), rheumatic and 
dysmetabolic diseases (8,9). Major salivary glands contribute to most of the secretion 
volume and electrolyte content of saliva (the parotid, submandibular, and sublingual 
glands, which account for 90% of saliva production), whereas minor salivary glands 
contribute little secretion volume and most of the blood-group substance
 
(10). 
Most patients diagnosed with head and neck cancer (HNC) receive radiotherapy as part 
of their cancer treatment. Head and neck cancer (HNC) actually includes many different 
malignancies. The most common type of cancer in the head and neck is squamous cell 
carcinoma, which originates in the cells that line the inside of the paranasal sinuses, 
nasal cavity, salivary glands, oral cavity, esophagus, pharynx and larynx (11). 
Worldwide, lip and oral cavity cancer along with thyroid cancer have the highest 
incidence; esophagus cancer is the most aggressive presenting a 4.9% mortality rate 
(Table 1). Similar findings regarding the incidence, mortality and prevalence of cancer 
in the European Union have been reported. The highest mortality rate belongs again to 
esophagus cancer with a predominance of 2.3% (Table 2). 
 HNC patients receive radiotherapy before, during, or after surgery as part of their 
cancer treatment. Routinely, HNC patients receive a dose between 50 and 70 Gy once a 
day for five days a week, (2 Gy per fraction) (12); on the other hand, if the radiotherapy 
protocol is just pre-operative, the total amount of radiation is usually lower. Conformal 
radiotherapy (CRT) is the most common type of radiotherapy used for the treatment of 
HNC; a special attachment to the radiotherapy machine carefully arranges the radiation 
beams to match the shape of the cancer, reducing the radiation to the surrounding 
healthy cells. Another similar type of radiotherapy used against HNC, known as 
intensity-modulated radiotherapy (IMRT), allows a more accurate delivery of specific 
radiation to be distributed to the tumor mass according to its location and severity, 
sparing the tissue and organs at risk, e.g., salivary glands (10). This radiation dose 
normally is used to destroy malignant cells and very often leads to the onset of salivary 
gland hypofunction and chronic xerostomia (13), that are the most common 
complications and occur to some degree in up to 100% of patients, severely impairing 
their quality of life (14).  
The main problem, which correlates the xerostomia to radiotherapy is the anatomical 
location of the salivary glands. In fact, the salivary glands are superficially located 
compared to most head and neck tumors, and thus, the ionizing radiation has to pass 
through the salivary glands to effectively treat the tumor (15). There are differences 
among the various type of salivary glands; in fact, the submandibular gland is less radio  
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sensitive than the parotid gland
 
(16). From this point of view, the most severe and 
irreversible forms of salivary gland hypofunction result from the damage/loss of 
salivary acinar cells, giving rise to rapid and predictable compositional changes, 
reduction in saliva production and in the quality of the flow. 
Radiotherapy can cause some temporary side effects. Although these may be worse if 
the treatment is combined with chemotherapy, they gradually disappear after the 
treatment has finished. Most radiotherapy side effects occur towards the middle and end 
of the course of treatment and continue during the first couple of weeks after the 
treatment. The effects can be mild or more troublesome, depending on the dose of 
radiotherapy and the length of treatment. Thus, the quantitative and qualitative salivary 
changes predispose the irradiated patient to a variety of problems. 
The final degree of damage to gland tissue depends on individual patient characteristics, 
such as pre-treatment already done, age, and sex. 
Xerostomia may affect the 80% of the patients who need radiotherapy as a primary 
treatment, as an adjunct to surgery, in combination with chemotherapy, or as palliation 
(17-19).  Hyposalivation represents the biggest acute side effect in HNC radiotherapy. 
The reduced secretion rates and the alteration in the quality of saliva in irradiated 
patients are due to irreversible fibrosis and atrophy of the gland parenchyma (20), as 
well as damage to the extra glandular blood vessels or nerve structures (21). The major 
reduction of salivation after radiotherapy is observed in the period from the onset of 
radiotherapy to three months after completion.  During radiotherapy, the first ten days 
are the worst ones as a massive decrease in saliva production occurs; especially in the 
first week, it could reduce by 50% to 60%
 
(Fig. 1) (22). After this period the flow rate is 
reduced by less than 10% of the initial conditions (Fig. 2) (23). The salivary 
composition may change and it becomes more viscose than usual, so its colour may turn 
yellow, brown or even white (Fig. 3).  
As a consequence of a reduction in the rate of saliva flow, which is correlated to the 
amount of radiation given to the patient, oral complications occur (16). The buccal 
mucosa has a dry and sticky appearance (Fig. 2). The normally moist, glistening 
appearance of the oral cavity is often replaced with a thin, pale, cracked appearance that 
is more susceptible to gingivitis and bleeding. Another frequent acute side effect is oral 
mucositis, which can be experienced by more than 50% of patients receiving HNC 
radiotherapy (Fig. 1). Some typical side effects are onset of erythema, edema and pain 
in the oral mucosa (24). Furthermore, the lack of saliva may lead to angular cheilitis, 
cracked lips (Fig. 4), periodontal disease, aching of the mouth and halitosis.  
When part or all of the mouth is treated, the sense of taste may change quickly during 
the radiotherapy and some patients may even either lose their sense of taste completely 
or find that everything tastes the same (usually rather metallic or salty). Changes in taste 
are correlated to the direct irradiation of the taste buds, and also to the reduction in 
salivary flow rate that alters the ionic composition of saliva that is related to the 
sensation of taste (25). 
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Moreover, the loss of saliva compromises mastication and nutrition. Some patients lose 
their appetite as a general effect of radiotherapy. Dryness of the mouth and lips can 
cause discomfort, ranging from a mild irritation to a severe burning sensation with 
difficulties in normal eating habits, particularly eating spicy or acidic food.  
A sore, dry mouth can also make eating and swallowing difficult, because moistening of 
food is insufficient and oral mucosa surfaces are not wet and not lubricated enough (26). 
Furthermore an insufficient lubrication, due to a diminished salivary output, causes 
intolerance to prosthetic appliances, so more friction is present between the mucosa and 
the resin that can injure the delicate irradiated epithelial layer. In addition, the 
inadequate presence of saliva weakens the stability of prostheses in the mouth. 
Ulceration is more likely because the dry mucosa is more vulnerable to trauma. 
A further complication that tends to occur later in irradiated patients is the increased 
risk of developing dental caries and oral infections, due to the alterations in the saliva 
flow and consequently in oral microflora (27). The decay is most often recurrent or 
primary and located at sites generally not usually susceptible to caries such as the 




Dentine Hypersensitivity in xerostomic patients after radiotherapy. 
Saliva plays an essential role for the health condition of the oral cavity (28). Saliva 
components interact in related functions in the following general areas:  
1) bicarbonates, phosphates, and urea act to modulate pH and the buffering capacity of 
saliva;  
2) macromolecule proteins and mucins serve to cleanse, aggregate, and/or attach oral 
microorganisms and contribute to the dental plaque metabolism; 
3) calcium, phosphates, and proteins work together as an antisolubility factor and 
modulate demineralization and remineralization of tooth surfaces; 
4) immunoglobulins, proteins, and enzymes provide antibacterial action. 
Thanks to the properties to humidify and lubricate the soft and hard tissue, saliva plays 
protective effects of the tissues, among which the preventing of mechanical damage. As 
regard to the tooth structural integrity, the buffering effect of the saliva is very 
important in the control of demineralization/remineralisation process (28-30). 
Physiologically saliva is supersaturated with respect to the tooth mineral content. 
Among the inorganic components, bicarbonate is related to saliva buffering capacity, 
while calcium, fluoride and phosphate are necessary for remineralisation allowing for 
the maintenance of tooth mineral integrity (31). 
As a consequence of a reduction in the rate of saliva flow, which is correlated to the 
amount of radiation given to the patients, oral complications will occur (32). An 
increase of Dentine Hypersensitivity (DH) may represent one of the most common 
manifestations that affects patients after radiotherapy (33-36).  
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DH is characterized by a short and sharp sensation of pain arising from the tubular 
dentine exposure as a result of enamel loss and/or gingival root surface exposure due to 
attrition, abrasion, erosion, abfraction or gingival recession (37) (Fig 2). Any thermal, 
osmotic and mechanical stimuli induced by the application of tooth brushing, sweet and 
acid foods, hot or cold drinks may provoke pain referred to fluid shifts in the exposed 
      a   ubu    w  h ac   a  o  of  h  pu p       , acco       o “B ä     öm’  
hy  o y am c  h o y” (37-40) (Fig. 5).   
Therefore, the occlusion of the tubules by different materials may reduce the fluid 
movement inside the dentinal tubules and the clinical symptoms of DH (39). When 
reducing fluid movement by fully or partially occluding open dentine tubules, 
hypersensitivity could be diminished (41). Consequently, most desensitizing agents 
have been designed to cover the dentine surface with occlusion of the exposed tubules 
or penetration in the tubules, coating and sealing them (39,26-30) (Fig 6).  
However, the efficacy of desensitizing agents is quite variable in long term, as reported 
in our previous studies and other clinical outcomes conditions (42 – 46).  Clinical data 
show that the desensitizing capacity has been correlated to the ability of the material to 
resist in front of the interactions of saliva and other oral ambient interferences (46). 
Moreover, differences in the efficacy were attributed to the different chemistries of the 
materials and application modalities required by the desensitizer itself (47-50).. 
Several different formulations of resin-based materials have being used in DH 
treatment. Four different kind can be summarized: 1) varnishes, usually with fluoride, 
creating a coat of calcium fluoride precipitates on the exposed surface and dentinal 
tubules (51,,52-54); 2) adhesive monomeric systems, with or without the etching phase, 
able to seal the exposed surface by a layer of interdiffusion in dentine and tubular resin 
plugs (47-49, 55); 3) resin sealants and 4) flowable resin composites able to form 
covers on the dentine surface (56) which sealing capacity in the time is influenced by 
the resin composition and the coupling between filler and  matrix (57). 
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Rational of the study. 
 
Twenty-four patients about to start radiotherapy for HNC were subjected to dental 
check up at the Dental Clinic of the University of Sassari, during and after the treatment 
in 2013, alongside with an on-going evaluation study of DH patients with normal 
salivary flow. Few months after the end of radio-exposition, 8 patients began to 
complain DH. Our research team started to study if a correlation between their health 
status and the clinical symptoms has been already described in the literature. With a 
systematic approach, a literature search for articles related to the Radiotherapy 
Xerostomia and DH, published between 01/01/1990 and 31/06/2013, was conducted in 
the databases MEDLINE/PubMed, Scopus and The Cochrane Library, using 
combinations of the MeSH terms: [Head and Neck Cancer] OR [Salivary 
Hyposalivation] OR [Xerostomia] OR [Radiotherapy] AND [Dentin Hypersensitivity]. 
Th     c  o  c   a ch       ’        fy a y   u        a       h   a  o h  ap u  c 
xerostomia and dentin hypersensitivity. 
In the light of the results obtained, the research team decided to change the experimental 
protocol of the on-going study, adapting it to the clinical condition of patients 
undergoing radiation therapy. 
The aim of the new clinical evaluation was to evaluate the 3-month efficacy of 4 kinds 
of dental materials used as desensitizing agents, especially focusing on the differences 
in DH reduction between the tested materials after the observation period. In addition, 
the difference of the desensitizing agent efficacy among xerostomic patients and 
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The owerall aim of this thesis was to collect knowledge about radiation-induced 
hypofunction, xerostomia and dentine hypersensitivity in head and neck cancer patients. 
In more detail, the aims of this thesis were: 
 
 To review the current state of knowledge of pathology, clinical complications 
and radiotherapeutic patient management 
 To evaluate the aetiology of dentine hypersensitivity in conditions of reduced 
salivary flow resulting in the radiation exposure 
 To evaluate the effectiveness of the materials commonly used in the treatment of 
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Systematic Review methodology 
Search strategy  
A first systematic literature search for articles published between 01/01/1970 and 
30/06/2013 was conducted in the databases MEDLINE/PubMed and The Cochrane 
Library, using combinations of the MeSH terms: [Saliva] OR [Salivary Glands] OR 
[Saliva Flow] OR [Salivation] OR [Salivary Gland Diseases] OR [Xerostomia] OR 
[Saliva in Xerostomia] OR [Dry Mouth] OR [Oral Dryness] OR [Composition Saliva 
Xerostomia] AND [Head and Neck Cancer] OR [Radiotherapy] OR [Radiation-induced 
Xerostomia] OR [Parotid-Sparing Intensity-Modulated Radiotherapy] AND [Quality of 
Life Analysis-Xerostomia] OR [Management Strategies Salivary Gland Hypofunction] 
OR [Prevention Xerostomia] OR [Treatment Xerostomia]. The search results were 
imported into a computerized database Review Manager 5.2. The search results from 
each of the electronic databases of MEDLINE/PubMed and The Cochrane Library were 
combined, and duplicated publications were eliminated. Subsequently, an update to 
include studies published up to 30/06/2013 was performed. 
 
Criteria for selecting studies 
After completing the search, articles for review were selected based on:  
• English language  
• Original data of cancer therapies protocols 




The reasons for exclusion were defined as follows: 
• Studies without original and/or actual data 
• Studies with data from previous publications  
• Opinion papers  
• Editorials  
 
In this way, a preliminary set of potentially relevant publications, removing irrelevant 
citations according to the criteria was created. Two reviewers (RP and GC) 
independently screened the registered title and abstracts, author and references in two 
separate files (one for included abstracts and one for excluded abstracts) using a 
screening guide based on eligibility criteria. Studies rejected at this or subsequent stages 
were reported in the table of excluded studies. The full text of all potentially eligible 
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studies in at least one screening was retrieved. Reviewers then evaluated the full text for 
inclusion using a screening guide and a second reviewer (RP) screened all the findings. 
When disagreement occurred, a third reviewer (IM) was consulted. For each review, the 
following information was recorded: Year, Authors, Journal, Aim and Number of 
Papers Reviewed; and for Clinical Trial Papers included: Year, Authors, Journal, Aim, 
Number of Patients and Results. All studies meeting the inclusion criteria then 
underwent validity assessment. Two examiners (RP and GC) read the papers 
independently. The qualities and relevance of each study were graded as follows: high 
(+++), medium (++) or low (+) using a study-quality checklist. External validity, 
internal validity and study precision were analysed to obtain an overall assessment of 
quality. The assessment was used as a basis for the discussion between the two 
examiners to grade the studies. In the case of disagreement, all authors discussed the 






Elemental analysis  
The elemental composition of Vertise Flow
TM
, Universal Dentine Sealant and Flor-
Opal® Varnish was investigated using an X-ray energy dispersive spectrometer (EDX) 
(INCA-X-acta, Oxford Instruments, Tubney Woods Abingdon, Oxfordshire, UK) in 
conjunction with an environmental scanning electron microscope (ESEM) (EVO
®
 LS 
25, Zeiss, Oberkochen, Germany). EDX was carried out using an accelerating voltage 
of 20 kV and ESEM was used for imaging of each sample at standardized magnification 
(200X, 1000X).  
For the semi-quantitative X-ray analysis VF, UDS and FOV (0.5 mL) were weighed, 
placed in a thin layer over Perspex
®
 slabs mounted on aluminum stubs (Agar Scientific, 
Stansted, UK). Three stubs were made for each tested material and the analysis was 
performed twice for each sample. The elemental analysis (weight % and atomic %) was 
performed in low-vacuum conditions (20 Pa). Atomic number, absorption, and 
fluorescence corrections were applied during the analysis with the ZAF correction 
method.  
 
Experimental design  
Subjects who had hypersensitive teeth were selected from an ongoing program of 
evaluating desensitizing agents at the Dental Clinic of the University of Sassari. Two 
clinicians selected patients complaining about hypersensitivity and who had reported 
this to the Department of Periodontology at the Dental Clinic. The protocol and 
informed consent forms were approved by the ethics committee at the University of 
Sassari (n° 1000/CE). The medical and dental history of the patients was collected, and 
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sensitive teeth were differentiated from other clinical conditions which frequently 
     f    w  h DH. A    h   ubj c   w     ho ou h y   fo m   abou   h    u y’  pu po  , 
risks, and benefits. A total of 86 patients with hypersensitive teeth were collected after 
an intake period of 8 months. The study inclusion/exclusion criteria were the following: 
1) patients were considered suitable for the study if they had sensitive teeth showing 
abrasion, erosion or recession with the exposure of the cervical dentine; 2) teeth with 
subjective or objective evidence of carious lesions, pulpitis, restorations, premature 
contact, cracked enamel, active periapical infection, or which had received periodontal 
surgery or root-planning up to 6 months prior to the investigation were excluded from 
the study. Other exclusion criteria were professional desensitizing therapy during the 
previous 3 months, or use of desensitizing toothpaste in the last 6 weeks. Patients were 
also excluded if they were under significant medication that could have interfered with 
pain perception (e.g., antidepressants, anti-inflammatory drugs, sedatives, and muscle 
relaxants). As a consequence, the total study population included in the program was of 
74 subjects, 43 female and 31 male,  aged 27- 75 years (mean age ± standard deviation: 
53  ± 7 years) with a total of 286 hypersensitive teeth (mean teeth for patient 2 ± 1). The 
level of sensitivity experienced by the patient was considered as independent of the 
position of the hypersensitive tooth in the oral cavity. 
 
Morphological study 
VF,  D  a   FOV’ , ability to occlude dentine tubules and their morphology on 
dentinal surfaces were evaluated in 30 selected patients, 18 female and 12 male, part of 
the total sample of 74 subjects with hypersensitive teeth.  Patients had 30 
hypersensitivity teeth (11 premolars, 13 incisors, 6 cuspids), whose Grade III mobility 
and significantly reduced response to periodontal treatment suggested the need for 
extraction. 
A full medical and dental history was taken and all the teeth were carefully examined to 
confirm the diagnosis of DH. The nature and scope of the study was explained, and 
informed consent was obtained. 
A week before treatment, patients received oral prophylaxis and were randomly 
assigned to three experimental groups (N=10 per group). The treatments were carried 
out at random by one of the clinicians while the other assisted. The teeth were isolated 
with cotton rolls and the treatment with VF, UDS and FOV was performed as 
summarized in Table 1. As recommended, a halogen curing light (Optilux 501, Kerr 
Corporation, USA; 11mm exit window) under the standard curing mode (output 
wavelength range: 400–505 nm; output irradiance: 580–700mW/cm2) was used to 
allow light curing of VF. After the treatment, teeth were immediately extracted (N=5 
per subgroup), subgroup 1, and after 7 days post-treatment (N=5 per subgroup), 
subgroup 2.  
After extraction, samples were rinsed with
 
distilled water at 37°C and fixed in a solution 
of 2.5% glutaraldehyde in 0.1 M PBS buffer (pH 7.2) for 72 h. In each sample, the 
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treated cervical dentine was sectioned from the remaining crown and roots of the tooth 
with a water-cooled saw (Isomet low-speed saw; Buehler, Lake Bluff, IL, USA) and 
then fractured into two halves in order to analyze the buccal surface and the longitudinal 
surface of the material-treated dentine surfaces. Samples were post-fixed in 1% osmium 
tetroxide, dehydrated in increasing concentrations of acetone (25%  100%), dried by 
critical point drying, and metal-coated. Specimens were then observed using a scanning 
electron microscope (SEM) (Zeiss, DSM 962, Oberkochen, Germany). Observations 
were recorded at standardized magnifications (1000×, 3000×, 5000X).  
 
Clinical study  
The study population consisted of another 36 patients, 19 females and 17 males who 
were randomly selected from the total population of 74 subjects who had hypersensitive 
teeth.  A total of 90 teeth (30 premolars, 44 incisors and 16 cuspids constituted the 
group of hypersensitive teeth for the clinical effectiveness of VF, UDS and FOV.  
A week before the experiment, patients received oral prophylaxis. Non-fluoride 
toothpaste, soft toothbrush and oral hygiene instructions were also provided in order to 
have standardized habits during the period of the study.    
Teeth were randomly assigned to three groups (N=30 per group) for the treatment with 
the three desensitizing agents (Table 1). At the baseline visit, they were reassessed for 
dentine hypersensitivity using the Visual Analogue Scores (VAS) of pain. Treatment 
was performed by one examiner, while the pain stimulus was given by the other 
examiner with the same equipment yielding similar air pressure each time.  
The VAS scale consisted of a horizontal line that was 100 mm long, on which "no pain" 
was marked on the right-hand extremity and "unbearable pain" on the other. The 
patients expressed the intensity of the pain experienced by placing a mark at any point 
along the continuum.  The distance, expressed in millimeters, from the right edge of "no 
pain" was used as the VAS score. Each patient was asked to rate the perception of 
discomfort after the application of air via a dental syringe at 45 to 60 psi, 1cm at the 
cervical third of the tooth after removing supragingival plaque with a low-speed 
handpiece with pumice powder and without fluoride. The adjacent teeth were covered 
by cotton rolls. The stimulus was delivered until reaction or up to a maximum duration 
of 10 seconds by the same examiner with the same equipment yielding similar air 
pressure each time. The subject's response was considered as the baseline measurement 
(PRE-1) -mean±standard deviation VAS score: 5.3±2.1. Before the application of the 
material (PRE-1), immediately after (POST-1), and after 7 days of oral environment 
(POST- 2), the same clinician carried out the sensitivity test. 
To compare the efficacy of the treatments, teeth were evaluated as a statistical unit 
rather than a subject. Data were elaborated using parametric tests (ANOVA for more 
 ha   wo  amp    a ju     acco       o    ak’  mu   p          ) w  h a 5%      f ca c  
level. 
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Fig. 7 - Summary of the experimental design to collect hypersensitivity teeth to test the efficiency of 







The study was designed as a split-mouth randomized clinical trial. The protocol and 
informed consent forms were approved by the ethics committee at the University of 
Sassari (n° 1000/CE). Subjects who had hypersensitive teeth were selected from an on-
going program of evaluating desensitizing agents at the Dental Clinic of the University 
of Sassari, Italy.  
Two examiners selected patients complaining about hypersensitivity and who had 
reported this to the Department of Periodontology at the Dental Clinic. The medical and 
dental history of the patients was collected, and sensitive teeth were differentiated from 
other clinical conditions that frequently interfere with DH. To participate in the study, 
the subjects had to have two or three teeth that were hypersensitive to the stimulation 
with a blast of air.  
All the subjects were thorough y   fo m   abou   h    u y’  pu po  ,    k , a   
benefits. A total of 86 patients with hypersensitive teeth were collected. The study 
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inclusion/exclusion criteria were the following: 1) patients were considered suitable for 
the study if they had sensitive teeth showing abrasion, erosion or recession with the 
exposure of the cervical dentine; 2) teeth with subjective or objective evidence of 
carious lesions, pulpitis, restorations, premature contact, cracked enamel, active 
periapical infection, or which had received periodontal surgery or root-planning up to 6 
months prior to the investigation were excluded from the study. Other exclusion criteria 
were professional desensitizing therapy during the previous 3 months, or use of 
desensitizing toothpaste in the last 6 weeks. Patients were also excluded if they were 
under significant medication that could have interfered with pain perception (e.g., 
antidepressants, anti-inflammatory drugs, sedatives, and muscle relaxants). As a 
consequence, the total study population included in the program consisted of 46 
patients, 27 females and 19 males who were randomly selected from the total 
population of 74 subjects who had hypersensitive teeth. A total of 116 teeth (52 
incisors, 38 premolars, and 26 cuspidates) were included in the study.  
 
Clinical Procedure 
VF self adhering composite was compared to: Universal Dentin Sealant (UDS) 
(Ultradent Products Inc., South Jordan, UT, USA), a biocompatible, non-polymerizable, 
high molecular weight resin sealant in alcohol solvent, Clearfil Protect Bond (CPB), 
(Kuraray Noritake Dental, Osaka, Japan) a methacrilate-based resin, self-etching 
adhesive system, and Flor-Opal® Varnish (FOV), (Ultradent Products Inc., South 
Jordan, UT, USA), a fluoride-based varnish.  
A week before the experiment, patients received oral prophylaxis. Non-fluoride 
toothpaste (Biorepair, Coswell), soft toothbrush (Oral-B Sensitive Advantage, Procter & 
Gamble) and oral hygiene instructions were also provided in order to have standardized 
habits during the period of the study.  
In view of the treatment with the desensitizing agents, teeth were randomly assigned in 
to four groups (N=29 per group) (Fig. 8). The level of sensitivity experienced by each 
patient was considered as independent of the position of the hypersensitive tooth in the 
oral cavity 11]. The pain experience was assessed using a Visual Analogue Scores 
(VAS) graded from 1 to 10, according to the same procedure of a previous study (56). 
The pain stimulus was given by one examiner with the same equipment yielding similar 
air pressure each time, while the other one performed the treatments. The subject's 
response was considered before the application of the material (PRE-1), immediately 
after (POST-1), after 1 week (POST- 2), 4 weeks (POST- 3) and 12 weeks (POST-4) of 
oral environment, the same operator carried out the sensitivity test. None of the 





Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  




Shapiro-Wilk normality test was used to assess the normality distribution of the 
collected variables. Median and inter-quartile ranges were used as measures of central 
tendency and variability to describe quantitative variables. Statistical differences in the 
Visual Analogue Scale (VAS) values of VF, UDS, CPB and FOV were performed using 
the Kruskall-Wallis analysis at the different time-points, adjusting statistical 
significance for the multiple comparisons (Bonferroni correction). Statistical differences 
at the baseline VAS value and the other time-points were calculated performing the 
Mann–Whitney U test. Statistical analysis was carried out using IBM® SPSS® 
Statistics, Version 21.0 (IBM Corporation ©, Armonk, NY, USA) and STATA®13 
(StataCorp, College Station, TX, USA). 
 
 
Fig. 8 - Summary of the experimental design to collect hypersensitivity teeth to test the efficiency of 
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The study was designed as a split-mouth randomized clinical trial. The protocol and 
informed consent forms were approved by the ethics committee at the University of 
Sassari (n° 1000/CE). Radio-therapeutic patients who had hypersensitive teeth were 
selected from an on-going program of evaluating desensitizing agents at the Dental 
Clinic of the University of Sassari, Italy.  
During 2013, a total of 48 patients were visited at the Department of Radiology. 24 
patients, which needed radiotherapy for HNC were collected. These groups of patients 
were subjected to a dental check-up with eventual teeth treatments, during and after the 
radiotherapy. Few months later the end of the radio-exposition, 8 patients began to 
complain HD. 
To pa   c pa       h    u y a    h   ubj c   w     ho ou h y   fo m   abou   h    u y’  
purpose, risks, and benefits. 
The study inclusion criteria were the following: 
 A relative good general health status; 
 A clinical reduction of salivary flow; 
 Two or three teeth that were hypersensitive to the stimulation with a blast of air. 
In addition, patients were considered suitable for the study if they had sensitive teeth 
showing abrasion, erosion or recession with the exposure of the cervical dentine. 
The study exclusion criteria were:  
 teeth with subjective or objective evidence of carious lesions, pulpitis, 
restorations, premature contact, cracked enamel, active periapical infection; 
 received periodontal surgery or root-planning up to 6 months prior to the 
investigation; 
 professional desensitizing therapy during the previous 3 months 
 use of desensitizing toothpaste in the last 6 weeks. 
Patients were also excluded if they were under significant medication that could have 
interfered with pain perception (e.g., antidepressants, anti-inflammatory drugs, 




All salivary assessments were performed in the absence of acute sialadenitis. The flow 
rate was determined in every person according to the method described by Sreebny 
(58). Saliva was collected in a standardised manner. Patients were instructed not to eat, 
drink, or smoke for 90 minutes before the sialometric assessment. All assessments were 
performed at a fixed time of the day, between 10 am and 1 pm, in order to minimise 
fluctuations related to a circadian rhythm of salivary secretion and composition. All 
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assessments were performed by the same observer. Whole saliva was collected in pre-
weighed plastic tubes using an electronic scale. 
Unstimulated salivary secretions were collected for 5 min with the patient seated in an 
upright position and with the tilted head. When possible the tongue, cheeks and lips 
movements were limited during the procedure. At the end of the collection period, the 
patient had to expectorate saliva into the test-tube.Stimulated whole saliva was collected 
asking to patients to chew a small block of paraffin wax or chewing gum. All the saliva 
secreted for 5 min was then collected in the test-tube.Measuring vessels were weighed 
after each collection using an electronic scale, and salivary flow rate was expressed in 
ml/min, which is nearly equivalent to g/min (59). A secretion rate < 0.1-0.2 ml/min for 
unstimulated flow and < 0.5-0.7 ml/min for stimulated flow was considered as an 
objective sign of hyposalivation. 
 
Assessment of hypersensitivity and desensitizing agents application. 
A week before the experiment, patients received oral prophylaxis. Non-fluoride 
toothpaste (Biorepair, Coswell), soft toothbrush (Oral-B Sensitive Advantage, Procter & 
Gamble) and oral hygiene instructions were also provided in order to have standardized 
habits during the period of the study.  The level of sensitivity experienced by each 
patient was considered as independent of the position of the hypersensitive tooth in the 
oral cavity (30). The pain experience was assessed using a Visual Analogue Scores 
(VAS) according the methodology described in the previous studies. 
The following dental materials were used following manufacture instructions: Vertise 
Flow
TM 
(VF) (Kerr Corporation, Orange, CA, USA), a self-adhering composite; 
Universal Dentin Sealant (UDS) (Ultradent Products Inc., South Jordan, UT, USA), a 
biocompatible, non-polymerizable, high molecular weight resin sealant in alcohol 
solvent; Clearfil Protect Bond (CPB), (Kuraray Noritake Dental, Osaka, Japan) a 
methacrilate-based resin, self-etching adhesive system, and Flor-Opal® Varnish (FOV), 
(Ultradent Products Inc., South Jordan, UT, USA), a fluoride-based varnish.  
All 8 patients were considered eligible and agreed to take part in the study. In view of 
the treatment with the desensitizing agents, teeth were randomly assigned into four 
groups (N= per group) (Fig. 9). None of the participants failed to complete the study 
neither reported any adverse reactions. 
 
Statistical Analysis 
Shapiro-Wilk normality test was used to assess the normality distribution of the 
collected variables. Median and inter-quartile range were used as measures of central 
tendency and variability to describe quantitative variables. Statistical differences 
between Visual Analogue Scale (VAS) values of Vertise FlowTM, Universal Dentine 
Sealant, Clearfil Protect Bond and Flor-Opal® Varnish were evaluated performing 
Kruskall-Wallis analysis at different time points, adjusting statistical significance for the 
multiple comparisons (Bonferroni correction). Statistical differences between baseline 
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VAS values and those obtained at other time-points were calculated performing the 
Mann–Whitney U test. Statistical analysis was carried out using IBM® SPSS® 
Statistics, Version 21.0 (IBM Corporation ©, Armonk, NY, USA) and STATA®13 
(StataCorp, College Station, TX, USA). 
Statistical differences between VAS values of xerostomic group and  normo-salivation 
group were calculated performing the Mann–Whitney U test. Statistical analysis was 
carried out using STATA®13 (StataCorp, College Station, TX, USA). 
 
 
Fig. 9 - Summary of the experimental design to collect hypersensitivity teeth to test the efficiency of 













Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  





Review research result  
(Paper I) 
 
The electronic searches identified about a thousand titles and abstracts, and after 
reviewing the titles 411 studies were evaluated. Subsequently, during the review of the 
abstract, 336 studies were excluded. The final analysis included 70 articles that 
conformed to the criteria for the present review (Fig. 10). Although animal studies have 
been excluded, important information regarding the experimental results on two of the 
papers was considered useful and therefore they were discussed.  
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VF treatment left a layer of highly visible randomly distributed 5 to 40 µm particles. 
Spectra of silicion (Si), ytterbium (Yb) alumina (Al) were highest in the layer in which 
also phosphorus (P), calcium (Ca), barium (Ba) and fluoride (F) were found.   
UDS treatment left fine, dispersed particles of about 0.5 µm in a thin and smooth layer. 
Spots on these particles showed very high pecks of Ca and chlorine (Cl). The semi-
quantitative analysis obtained by scanning different areas of the matrix highlighted Ca 
and Cl associated with Si and other oxides of Al, iron (Fe), chrome (Cr), potassium (K), 
sulphur (S), magnesium (Mg), titanium (Ti) and zinc (Zn). FOV treated samples 
showed a layer of particles embedded in a smooth matrix rich in sodium (Na) and F 
peaks and with traces of Si and P.   
 
Morphological study 
On the surface of the exposed dentine (ED) to the oral fluids, VF formed a thick, 
irregular coat that completely masked the underlying tubular dentine. Cracks were also 
noted in ED. Longitudinal sections showed a coating about 3 µm thick composed of a 
matrix with crystal-like particles of different sizes. Tubule orifices were tightly blocked 
by the material and plugs of resin-like material were found inside the tubules. After 7 
days of exposure to the oral environment (subgroup 2), tubular orifices were still not 
visible on ED treated dentin surface which showed cracks and gap formations. Crystal-
like precipitates were dissolving, but the tubular apertures remained occluded. 
UDS formed a smooth amorphous layer that contained particles about 0.5 µm in 
diameter, over dentine. Particles had a tendency to form clusters and adhered to the 
underlying dentine completely occluding the tubular orifices.  Longitudinal sections 
showed the dentine surface covered by a coating of UDS that was about 0.4 µm thick, 
and plug-like structures in the tubules. After exposure to oral environment for 7 days 
(subgroup 2), the dentine surface treated with UDS showed a residual coating of dentine 
with different representations of crystal-like particles.  Longitudinal sections showed a 
thick granular surface and peritubular dentine masking the intratubular space. 
Occasionally, small areas of separation between the surface coating and the dentine 
subsurface demonstrated the presence of a barrier-like structure with tag-like structures 
reproducing the tubular dentine. 
FOV treated dentine surface exhibited an amorphous layer with dispersed particles 
leaving most of the tubules partially occluded. Transverse sections of exposed dentine 
revealed a thick coating of varnish almost blocking the tubular apertures. After 7 days 
of exposure to the oral environment (subgroup 2), ED showed areas of solubilization of 
a surface coating with disclosure of the underling smear layer. The solubilization 
Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  
                  tudi di Sassari. 
 
27 
process involved the tubular blocks of varnish on ED simultaneously showing crystal-
like precipitates with reduction of the tubular diameter. 
Clinical Study 
The mean VAS scores are shown in Table 3. There was no difference among baseline 
VAS scores of all groups (P > 0.05). After treatment, all teeth exhibited statistically 
significant reductions in VAS in Post-1. Teeth treated with VF had lower VAS scores 
immediately after Post-1 control (VF vs. FOV: P =0.034). After 7 days of exposure to 
oral fluids (POST-2) there was no significant difference among tested materials, 
acco       o    ak’  mu   p           a ju  m   . How    , wh   compa    w  h 
baseline data, all the VAS scores at post-treatment evaluation points were significantly 
decreased (P < 0.05). 
 












Anova one way 

































Anova one way <0.01 <0.01 <0.01  




Clinical Analysis of long-term evaluation of DH treatment 
(Paper III) 
 
The sample size based on the initial assumptions showed a statistical power higher than 
80%. Table 4 shows the median VAS scores at the different time-points.  
At baseline (VAS score), no significant statistical differences were observed (p-value 
>0.05) among the groups. After the applications of the materials, statistical significant 
decrease of the VAS values was observed proceeding from Post-1 to Post-4 control.  
Teeth treated with VF showed lower VAS scores at Post-1 control when compared to 
UDS (p-value >0.001), CPB (p-value =0.001), and FOV (p-value >0.001), while at 
Post-2, a significant statistical reduction of the value was demonstrated in VF in 
comparison to UDS (p-value =0.001) and FOV (p-value =0.001). As far as the Post-3 
and Post-4 controls, no significant differences were detected in VF efficiency in respect 
to any other materials. Also, post-treatment values showed a significant decrease in the 
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The mean basal salivary flow rate was 0.24 ml/min (minimum 0.06 – maximum 0.42) 
while the stimulated rate was of 0.54 ml/min (minimum 0.29 – maximum 0.86). 
The median VAS scores at different time-points is shown in Table 6. No statistically 
significant differences between the baseline VAS scores were observed (p-value >0.05). 
Following the exposure to the materials, a statistically significant VAS decreases was 
observed from Post-1 to Post-3; no statistical differences were detected in the final 
point. Teeth treated with Vertise FlowTM  and Universal Dentine Sealant showed lower 
VAS scores at Post-1 in in comparison to those treated with Clearfil Protect Bond (p-
value <0.0001), and Flor-Opal® Varnish (p-value <0.0001). On the other hand, 
statistically significant lower VAS values were showed for Vertise FlowTM  and 
Universal Dentine Sealant in Post-2 when compared to Flor-Opal® Varnish (p-value 
=0.0002 and p-value<0.0001, respectively). Significantly higher VAS values were 
reported in regard to Flor-Opal® Varnish, Universal Dentine Sealant (p-value =0.0003) 
and Clearfil Protect Bond (p-value =0.0002). Conversely, no significant differences 
were detected at Post-4. In the case of Universal Dentine Sealant and  Clearfil Protect 
Bond, the baseline, Pre-1, and the post-treatment values Post-4 showed significant VAS 
 co     c  a   ,  Th   wa  ’      h  ca   of V       F owTM  a   F o -Opal® Varnish 
(Tab. 7). 
Moreover, no statistically significant differences (p-value >0.05) were detected at the 
baseline VAS when the xerostomic group was compared to the healthy (Table 8). 
Statistically lower VAS values were showed in the normo-salivation group treated with 
Vertise FlowTM , Clearfil Protect Bond and Flor-Opal® Varnish at Post-4 (p-value 
<0.05) (Table 9). 
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Management of patients with radio-induced xerostomia 
(Paper I) 
 
The treatment of xerostomia has four aims: increasing existing saliva flow or replacing 
lost secretions, the control of the state of oral health, the control of dental caries and the 
treatment of possible infections (60).   
Therapy options in xerostomia depend on the presence of residual secretion or the 
absence of it. When residual secretory capacity is present, it is advisable to regularly 
stimulate the salivary glands by mechanical or gustatory stimuli as supportive oral care. 
The use of sugarless chewing gum or candy containing xylitol or sorbitol can be 
recommended as a means of stimulating extra salivary flow to aid caries management 
and lubrication. Nocturnal oral dryness can be alleviated by applying a small amount of 
dentifrice on smooth dental surfaces, especially using anti-xerostomia dentifrices that 
contain three salivary enzymes, lactoperoxidase, glucose oxidase and lysozyme, 
specifically formulated to activate intra-oral bacterial systems.  
The salivary flow can b  a  o    mu a    by  h  u   of cho       c pha mac u  ca  
p  pa a  o  ,  uch a  p  oca p    o  c   m     . Th     wo pa a ympa hom m   c   u   
a   app o    by  h  Foo  a   D u  A m      a  o  fo     a m    of    o  om a  
p  oca p       app o    fo   jö    ’   y   om  a    a  o h  apy    uc      o  om a, 
wh    c   m         m   o b  mo    p c f ca  y fo   jo    ’   y   om . If  om  
residual function of salivary glands remains, acupuncture could be a good alternative 
treatment for alleviating radio-induced xerostomia (61) . The way this works remains 
poorly understood, but it seems that acupuncture modulates central nervous system 
processes (62), increasing the concentration of salivary neuropeptides, which seem 
capable of modulating the complex process of salivary secretion (63). However, the 
results of systematic reviews do not indicate the efficacy of acupuncture in the treatment 
of xerostomia due to the current lack of relevant randomized clinical trials (64 ,63-66). 
When stimulation of salivary secretion fails, patients can be given palliative oral care in 
the form of application of mouthwashes and saliva substitutes. Although the daily use of 
a mouthwash or one of the saliva substitutes, which are formulated to mimic natural 
saliva, is strongly recommended , they do not stimulate salivary gland production. 
Commercially available products come in a variety of formulations including solutions, 
sprays, gels and lozenges. In general, they contain an agent to increase viscosity, such 
as carboxymethylcellulose (CMC) or hydroxypropylmethylcellulose (HPMC), 
hydroxyethylcellulose (HEC), polyglycerylmethacrylate (PGM) (64), minerals such as 
calcium and phosphate ions and fluoride, preservatives such as methyl or 
propylparaben, and flavouring and related agents. In order to minimize problems related 
to the absence of or reduced secretion of saliva, all patients should be encouraged to 
take an active role in the management of their xerostomia; so a daily mouth 
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examination, checking for red, white or dark patches, ulcers or tooth decay, is highly 
recommended.  
Patients with reduced saliva should also be encouraged to consider visiting their dentist 
more frequently because they have got a greater susceptibility to dental problems. 
Dentures and acrylic appliances should not be worn during sleep and they should be 
kept clean by soaking them overnight in chlorhexidine. Sometimes, lubricants, vaseline 
and or glycerin based, put on the lips and under dentures, may relieve drying, cracking, 
soreness and mucosal trauma (67).   
Patients with decreased salivary flow also should be made aware of the necessity to 
comply with suggested oral hygiene regimens after exposure to acid-producing food 
sources. Recommendations for professional and home fluoride treatments should be 
considered carefully for patients with salivary dysfunction, especially those with high 
caries rates and exposed root surfaces. A modified diet can be useful to minimize the 
effects of xerostomia, for instance, they should avoid sugary or acidic foods and avoid 
also dry, spicy, astringent or excessively hot or cold foods that are more irritating, while 
eating foods such as carrots or celery may also help patients with residual salivary gland 
function. The addition of flavour enhancers such as herbs, condiments and fruit extracts 
may make food more palatable to patients complaining of their food tasting bland, 
papery, salty or otherwise unpleasant; at the same time, taking frequent sips of water 




Clinical evaluation of the efficacy of different desensitizers in dental 
hypersensitivity of patients with normal salivary flow. 
(Paper II and III) 
 
A 12-week evaluation was kept in consideration due to the fact that significant 
differences among the desensitizer effects may appear in long-term estimation of the 
agents (43,44,46). Factors involved in the efficiency of the desensitizers are first of all 
the intrinsic material performance, strictly related to the different formulation (52) and 
the active ingredient of the materials (45,55). The leach of ions by resins may affect the 
sealing capacity of the desensitizing agents in oral fluids (69.70). Another factor is the 
stability of the tubular occlusions produced by the agents, which is related to the 
composition of the blocks (53) finally derived by the interaction of the material 
components with the oral fluids (53,71).  
     Data obtained in this study demonstrated that of the VAS value was reduced after the 
application of VF and the other desensitizing agents when compared to the baseline. 
However, different responses could be observed in the post-treatment controls as a 
consequence of the material composition and interaction capacity in dentine under oral 
environment (Fig. 11). 
Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  




Fig. 11 – Trend of VAS Scores. 
 
Compared with the baseline, VF showed the ability to significantly reduce the 
sensitivity immediately after the application, however lowering its efficiency within the 
12-week post-treatments, as a possible loss of the resin sealing in dentine under oral 
fluids exposure. Under SEM, VF layer covered the exposed surface of dentine leading 
to tubular seals and reduction of sensitivity. The reduction of the tubular orifices can 
explain the significant decrease of DH, as any substance that causes a decrease of 
tubular radius is able to reduce clinical symptoms of DH by reducing fluid conductance 
(58). It is like, however, that the same chemical components of the composite mass 
might be responsible for the deterioration of the physico-mechanical properties of the 
resin cover within the 12-week controls. A hydrolytic breakdown has been supposed in 
VF in water mostly related to the presence of leachable ions of Si, Yt, F, and Ba (57), 
that may have allowed the permeation of water molecules into the spaces previously 
occupied by these ions (72,73). This process may explain a possible reduction of the 
strength of resin–filler interface, a weakening of the mechanical properties, and the 
chemical bond of VF in dentine.  
UDS revealed Ca, Cl, and Si as the highest ions in the resin matrix, also containing Al 
ion peaks (56). Clinically, the behaviour of the resin sealant was different to that of the 
self-adhesive composite. In comparison to VF, UDS produced a slowly but continue 
decrease of the VAS showing the higher most stable desensitizing effect at the 12-week 
controls. Results may be related to the different composition and filler treatment in UDS 
in respect to VF (56), leading to a filler-polymer bond probably less attackable by water 
degradation under oral exposure. Moreover, the different behavior of UDS in respect to 
VF, may suggest that the 12-weeks of oral environment would be essential for the 
sealant expression. 
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Clinically, CPB showed a significant decrease of the VAS in POST-1, that remained 
stable within the 12-week controls. The significant decrease in DH immediately after 
CPB application may be related to the high bonding capacity in tubular dentine. The 
strong adhesion in dentine may be the result of the 1) chemical bonding of the acidic 
functional monomer 10-MDP contained in the CPB allowing for a ionic interaction to 
the calcium in dentine (74), and 2) micromechanical bonding due to the fluoro-alumino-
silicate glasses in the filler capable to react with the acidic monomer following a typical 
glass-ionomer acid–base reaction (75). Still, the reduction in efficiency observed within 
the 12-week controls may be explained in the incapacity of the resin adhesive to resist 
in face to the fluid exposure unless a composite cover is performed (75). 
FOV, a resin varnish rich in Na and F, and Si and P traces (56)., clinically demonstrated 
low efficiency in DH when compared to the other materials. FOV showed a higher VAS 
score after the 12-week control. The initial reduction of VAS value by FOV may be 
explained by the presence of a cover of varnish on dentine with precipitation of 
crystallites of calcium fluoride or phosphate containing calcium fluoride in the opening 
of the tubules (42,53). This mechanism of covering, previous observed in vivo (56), is 
able to reduce the tubular apertures in exposed dentine with a decrease of tubular fluid 
conductance and DH (58), as was observed in POST-1. However, the progressive 
decline in effectiveness demonstrated the inability of the resin varnish to produce a firm 
seal in dentine (53,76) within the 12-week controls under environment.  
As a result of these investigations, all the materials tested produced a reduction of 
dentine permeability. However, after 12-week controls, there was no significant 





Clinical evaluation of the efficacy of different desensitizers in dental 
hypersensitivity of patients with radio-induced xerostomia 
(Paper IV) 
 
Due to the lack of information about DH in radiotherapeutic xerostomia, this study was 
undertaken to investigate the effectiveness of four different desensitizing agents with 
the purpose to identify the material of choice. Also, the response of the hyposalivary 
group was compared to a group of normosalivary patients in order to understand 
differences between the two groups.  
All the eight patients (101 teeth) completed the 12-week evaluation study. Data 
obtained in demonstrated that of the VAS value was significantly reduced after the 
application of all the materials (Tab. 6). This is really evident for VF and CPB, both 
showing an overall specular behaviour (Fig. 12). It could be speculated that the reduced 
presence of saliva, as found among the patients, was a determinant factor in this result. 
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In fact, one of the major factors in the reduction of the adhesive bond in dentine is the 
hydrolysis of the adhesive material within water exposure (77). In an oral environment 
with low saliva volume these materials could be able to increase their performance.At 
the same time, it could be speculated that the clinical condition of xerostomia, may 
lower the bonding in time. The occlusal stress, thermal stress and chemical attack by 
acid and enzymes may affect the adhesive sealing, compromising the integrity of the 
adhesive restoration (77). Consequently, comparing the data with those obtained in our 
previous evaluation (78), both the materials may have behaved overall in a less stable 
manner (Fig. 12).  
However, after 12-week controls, both VF and CPB showed a dramatically decrease of 
performance with reduction of the VAS scores in a similar manner to those observed at 
PRE-1 (Fig. 12). As reported in the previous study (78) (Fig. 12), UDS produced a slow 
but continue decrease of the VAS scores (Fig. 12). The results may be related to the 
proper composition of UDS and the presence of fillers in the resin mass of  (56). Unlike 
it  was previously reported, at 12-week controls UDS VAS decreases showing similar 
values to those noted at  PRE-1, similarly to VF and CPB (Fig. 12).  
As regard to FOV, it demonstrated the lower efficiency in DH when compared to the 
other materials (Fig. 12). As previous observed in vivo (56), the reduction of VAS 
scores in FOV is due to precipitation of crystallites of calcium fluoride or phosphate 
containing calcium fluoride in the opening of the tubules. In this study, FOV showed 
the higher VAS scores after the 12-week control. It could be speculated that the 
reduction of saliva might have affected the performance of the varnish as in the case of 
UDS and FOV. In light of these data, the first null hypothesis has been accepted: after 
12-week controls there is no statistically significant difference among all desensitizers 
(Tab. 6). Conversely, the second null hypothesis was rejected except in the case of 
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From the results of these studies the following conclusions were drawn: 
 
Xerostomia is a subjective symptom of a dry mouth often deriving from a lack 
of saliva that often suffer patients undergoing radiation therapy for the treatment 
of Head and Neck Cancers. HNC patients receive a radiation dose normally used 
to destroy cancer cells. The superficial anatomical position of salivary glands, 
compared to most head and neck tumors, causes the exposition to ionizing 
radiation, which very often leads to the onset of salivary gland hypofunction and 
chronic xerostomia (I). 
 
 Dentine hypersensitivity is a common and painful syndrome, predominately 
located on the cervical part of the tooth buccal surface. Dentine hypersensitivity 
arise from the tubular dentine exposure as a result of enamel loss and/or gingival 
 oo   u fac    po u  , acco       o “B ä     öm’  hy  o y am c  h o y”. The 
occlusion of the tubules by different materials may reduce the fluid movement 
inside the dentinal tubules and the clinical symptoms of DH. Unfortunately, 
there is already no gold standard for treatment of DH available today, able to 
guarantee a stable seal on dentin over (II,III). 
 
 Dentine hypersensitivity is one among the multiple complications in the oral 
cavity which is possible diagnose in patients affected by xerostomia post 
radiotherapy. It may occur as a result of the combination between the typical 
etiologic factors and the reduction in salivary flow, because it is lacking the 
essential protective role of saliva for tooth structural integrity, which consists in 
the buffering effect and demineralization / remineralization process control (IV).  
 
 The experimental data obtained from patients with normal salivary flow show 
that all the materials tested produced a reduction of dentine permeability. 
However, after 12-week controls, there was no significant statistical difference 
in the efficacy, irrespective of the desensitizing agent employed. This is a 
possible consequence of deterioration of the physical-mechanical properties of 
the resin cover in dentine (II,III). 
 
 In xerostomic condition all the materials tested produced a significant reduction 
in the dentine sensibility. In light of the observed data, the materials show a less 
stable behaviour compared to the normal salivation condition. After 12-week 
controls there is no statistically significant difference between the desensitizers. 
It is a possible consequence of deterioration of the physical-mechanical 
properties of the materials, that it could be related to the loss of the protective 
effect of saliva. Unfortunately it is not possible to indicate a long term 
therapeutic gold standard among the materials tested (IV). 
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Xerostomia induced by radiotherapy
most prevalent in the plaque of irradiated patients.30,36–38 
In a longitudinal study, Brown et al assessed the effects of 
radiation-induced xerostomia on the human oral microﬂora 
and on the subsequent development of dental caries.35 Five 
intraoral specimens consisting of resting saliva, gingival 
sulcus ﬂuid, dental plaque, lingual swabs, and stimulated 
whole saliva were collected from each patient two times 
during 1 week before radiation, one time per week during 
radiotherapy, at 3-month intervals during the ﬁrst postra-
diation year, and at 6-month intervals thereafter. During 
irradiation, the development of xerostomia was matched by a 
parallel and pronounced shift in certain microbial populations 
at each intraoral site assessed. The most prominent changes 
were the increase in S. mutans and species of Lactobacillus, 
Candida (primarily Candida albicans), and Staphylococcus, 
with parallel decreases in Streptococcus sanguis and species 
of Neisseria and Fusobacterium. Microbial differences were 
relatively minimal between the groups of patients receiving 
radiotherapy who used a ﬂuoride gel and a nonﬂuoride gel 
during the irradiation period. However, there was a more 
rapid decrease in the level of S. sanguis in the plaque of 
the patients using the nonﬂuoride gel compared with those 
patients using the ﬂuoride gel, and the subsequent develop-
ment of dental caries differed greatly. The increased number 
of Lactobacilli  was correlated to a high acidic potential of 
the plaque and the use of ﬂuoride was associated with a 
protective effect in the prevention of dental decay during 
xerostomia.
The ﬁndings that a high frequency, number, and propor-
tion of Lactobacillus spp. occur in irradiated patients were 
strengthened by a study of Almståhl et al who analyzed the 
saliva oral microbiota in subjects with hyposalivation using 
a rinsing technique and a cultivation technique. Results 
indicated that the salivary secretion rate, pH, and buffer 
capacity were the more important factors in the increase in 
Lactobacillus spp. A marked increase in C. albicans was also 
characteristic of the irradiated patients. 39
In a more recent study, Almståhl et al evaluated the 
frequency of different Lactobacillus spp. in relation to the 
pH-lowering potential of the supra-gingival plaque in irradi-
ated patients in comparison to primary Sjögren’s syndrome 
patients and controls with normal salivary secretion.40 The 
irradiated subjects had ﬁnished their bilateral radiation treat-
ment (64.6 Gy) 3–5 years before participating in the study. 
Interproximal plaque pH was measured by the microtouch 
method30 before and up to 60 minutes after a 10% sugar 
rinse.29 The measurements were performed at two sites: in 
the anterior and in the premolar/molar region. Data indicated 
that the most common species were Lactobacillus fermen-
tum, Lactobacillus rhamnosus, and Lactobacillus casei. In 
anterior sites, both the hyposalivated group subjects with 
high Lactobacillus counts had an increased plaque acidoge-
nicity compared to those with low counts. In posterior sites, 
subjects with high Lactobacillus counts had a lower ﬁnal pH 
compared with those with low counts. Authors concluded 
that hyposalivation patients often harbor several different 
Lactobacillus spp. in their supragingival plaque. There were, 
however, large differences in number and proportion of 
Lactobacilli  between individuals and between anterior and 
posterior dental sites, but no speciﬁc species could be related 
to plaque acidogenicity.
Radiotherapy clinical consequences
In eleven articles, the clinical consequences that may arise 
as a result of HNC radiation therapy have been described: 
three narrative reviews, one randomized clinical trial, one 
animal experimentation study, four cohort studies, and two 
cross-sectional studies.20,36,41–50 Radiotherapy can cause some 
temporary side effects. Although these may be worse if the 
treatment is combined with chemotherapy, they gradually 
disappear after the treatment has ﬁnished. Most radiotherapy 
side effects occur toward the middle and end of the course of 
treatment and continue during the ﬁrst couple of weeks after 
the treatment. The effects can be mild or more troublesome, 
depending on the dose of radiotherapy and the length of treat-
ment. Thus, the quantitative and qualitative salivary changes 
predispose the irradiated patient to a variety of problems.
Radiation therapy in HNC is inevitably associated with 
damages to the oral tissues and, in addition, the clinical 
consequences of radiotherapy include also dermatitis and 
osteoradionecrosis.41 In fact, salivary glands are often 
involved and, as a result, patients may have a salivary gland 
hypofunction, even if 3D planning and unilateral irradiation 
have considerably reduced the side effects by minimizing the 
dose to normal tissues. However, the ﬁnal degree of damage 
to gland tissue depends on individual patient characteristics, 
such as pretreatment already done, age, and sex.
Xerostomia may affect 80% of the patients who need 
radiotherapy as a primary treatment, as an adjunct to surgery, 
in combination with chemotherapy, or as palliation.42–44 
Hyposalivation represents the biggest acute side effect in 
HNC radiotherapy and, in general, is always associated with 
oral function problems, such as chewing and swallowing, or 
caries at a later stage. Normally, during radiotherapy, salivary 
composition may change and it becomes more viscose than 
usual, so its color may turn yellow, brown, or even white 
Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  














Xerostomia induced by radiotherapy
References
 1. Bivona PL. Xerostomia. A common problem among the elderly. N Y 
State Dent J. 1998;64:46–52.
 2. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. 
Gerodontology. 2003;20:64–77.
 3. Waltimo T, Christen S, Meurman JH, Filippi A. Dental care of 
patients with leukemia. Schweiz Monatsschr Zahnmed. 2005;115: 
308–315.
 4. Brand HS, Bots CP, Raber-Durlacher E. Xerostomia and chronic oral 
complications among patients treated with haematopoietic stem cell 
transplantation. Br Dent J. 2009;207:E17.
 5. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can 
Dent Assoc. 2006;72:841–846.
 6. Villa A, Abati S. Risk factors and symptoms associated with xerostomia: 
a cross-sectional study. Aust Dent J. 2011;56:290–295.
 7. Villa A, Polimeni A, Strohmenger L, Cicciù D, Gherlone E, Abati S. 
Dental patients’ self-reports of xerostomia and associated risk factors. 
J Am Dent Assoc. 2011;142:811–816.
 8. Busato IM, Ignácio SA, Brancher JA, Grégio AM, Machado MA, 
Azevedo-Alanis LR. Impact of xerostomia on the quality of life of 
adolescents with type 1 diabetes mellitus. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod. 2009;108:376–382.
 9. Moore P, Guggenheimer J, Etzel JK, Weyant RJ. Trevor orchard type 1 
diabetes mellitus, xerostomia, and salivary ﬂow rates. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod . 2001;92:281–291.
10. Jensen SB, Pedersen AM, Vissink A, et al; Salivary Gland Hypofunc-
tion/Xerostomia Section, Oral Care Study Group, Multinational Asso-
ciation of Supportive Care in Cancer (MASCC)/International Society 
of Oral Oncology (ISOO). A systematic review of salivary gland 
hypofunction and xerostomia induced by cancer therapies: prevalence, 
severity and impact on quality of life. Support Care Cancer . 2010;18: 
1039–1060.
11. Fox PC, Bunch KA, Baum BJ. Subjective reports of xerostomia and 
objective measures of salivary gland performance. J Am Dent Assoc. 
1987;115:581–584.
12. Porter SR, Scully C, Hegarty AM. An update of the etiology and man-
agement of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod. 2004;97:28–46.
13. De Graeff A, De Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, 
Winnubst JA. A prospective study on quality of life of patients with 
cancer of the oral cavity or oropharynx treated with surgery with or 
without radiotherapy. Oral Oncol . 1999;35:27–32.
14. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. 
Lancet. 2008;371:1695–1709.
15. IARC. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality World-
wide in 2012; IARC CancerBase [Internet]; 2010; Lyon, France.
16. Maciejewski B, Zajusz A, Pilecki B, et al; Salivary Gland Hypofunction/
Xerostomia Section, Oral Care Study Group, Multinational Association 
of Supportive Care in Cancer (MASCC)/International Society of Oral 
Oncology (ISOO). Acute mucositis in the stimulated oral mucosa of 
patients during radiotherapy for head and neck cancer. Radiother Oncol. 
1991;22:7–11.
17. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J 
Cancer B Oral Oncol . 1996;32:281–292.
18. Sreebny LM. Saliva in health and disease: an appraisal and update. Int 
Dent J. 2000;50:140–161.
19. Vissink A, Kalicharan D, S-Gravenmade EJ, et al. Acute irradiation 
effects on morphology and function of rat submandibular glands. J Oral 
Pathol Med. 1991;20:449–456.
20. Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A. Parotid 
and submandibular/sublingual ﬂow during high dose radiotherapy. 
Radiother Oncol . 2001;61:271–274.
21. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. 
Quality of life and oral function in patients treated with radiation therapy 
for head and neck cancer. Head Neck. 2001;23:389–398.
22. Franzén L, Funegård U, Ericson T, Henriksson R. Parotid gland function 
during and following radiotherapy of malignancies in the head and 
neck. A consecutive study of salivary ﬂow and patient discomfort. Eur 
J Cancer . 1992;28:457–462.
23. Dreizen SA, Daly TE, Drane JB, Brown LR. Oral complications of 
cancer radiotherapy. Postgrad Med. 1977;61:85–92.
24. Ben-Aryeh H, Gutman D, Szargel R, Laufer D. Effects of irradiation 
on saliva in cancer patients. Int J Oral Surg. 1975;14:205–210.
25. Dreizen S, Brown LR, Handler S, Levy BM. Radiation-induced xeros-
tomia in cancer patients. Effect on salivary and serum electrolytes. 
Cancer . 1976;38:273–278.
26. Marks JE, Davis CC, Gottsman VL, Purdy JE, Lee F. The effects of 
radiation of parotid salivary function. Int J Radiat Oncol Biol Phys. 
1981;7:1013–1019.
27. Ben-Aryeh H, Miron D, Berdicevsky I, Szargel R, Gutman D. Xerosto-
mia in the elderly: prevalence, diagnosis, complications and treatment. 
Gerodontology. 1985;4:77–82.
28. Abelson DC, Mandel ID. The effect of saliva on plaque pH in vivo. 
J Dent Res. 1981;60:1634–1638.
29. Lingström P, Birkhed D. Plaque pH and oral retention after consump-
tion of starchy snack products at normal and low salivary secretion rate. 
Acta Odontol Scand. 1993;51:379–388.
30. Eliasson L, Birkhed D, Osterberg T, Carlén A. Minor salivary gland 
secretion rates and immunoglobulin A in adults and the elderly. Eur J 
Oral Sci . 2006;114:494–499.
31. Almståhl A, Wikström M. Oral microﬂora in subjects with reduced 
salivary secretion. J Dent Res. 1998;78:1410–1416.
32. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilo-
carpine during head and neck radiation therapy to reduce xerostomia 
and salivary dysfunction. Cancer . 1993;71:1848–1851.
33. Makkonen TA, Tenovuo J, Vilja P, Heimdahl A. Changes in the 
protein composition of whole saliva during radiotherapy in patients 
with oral or pharyngeal cancer. Oral Surg Oral Med Oral Pathol . 
1986;62:270–275.
34. Izutsu KT, Truelove EL, Bleyer WA, Anderson WM, Schubert MM, 
Rice JC. Whole saliva albumin as an indicator of stomatitis in cancer 
therapy patients. Cancer. 1981;48(6):1450–1454.
35. Brown LR, Dreizen S, Handler S, Johnston DA. Effect of radiation-
induced xerostomia on human oral microﬂora. J Dent Res. 1974; 
54(4):740–750.
36. Keene HJ, Daly T, Brown LR, et al. Dental caries and Streptococ-
cus mutans prevalence in cancer patients with irradiation-induced 
xerostomia: 1–13 years after radiotherapy. Caries Res. 1981;15: 
416–427.
37. Hase JC, Birkhed D. Salivary glucose clearance, dry mouth and 
pH changes in dental plaque in man. Arch Oral Biol . 1988;33: 
875–880.
38. Ravald N, List T. Caries and periodontal conditions in patients with 
primary Sjögren’s syndrome. Swed Dent J. 1998;22(3):97–103.
39. Almståhl A, Wikström M, Groenink J. Lactoferrin, amylase and mucin 
MUC5B and their relation to the oral microﬂora in hyposalivation of 
different origins. Oral Microbiol Immunol . 2001;16:345–352.
40. Almståhl A, Carlén A, Eliasson L, Lingström P. Lactobacillus species 
in supragingival plaque in subjects with hyposalivation. Arch Oral Biol. 
2010;55:255–259.
41. Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of 
radiation-induced dermatitis, mucositis, and xerostomia. Am J Health 
Syst Pharm. 2013;70:1025–1032.
42. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, 
Schmitz PI. Patients with head and neck cancer cured by radiation 
therapy: a survey of the dry mouth syndrome in long-term survivors. 
Head Neck. 2002;24:737–747.
43. Sher DJ, Balboni TA, Haddad RI, et al. Efﬁcacy and toxicity of chemora-
diotherapy using intensity-modulated radiotherapy for unknown primary 
of head and neck. Int J Radiat Oncol Biol Phys. 2011;80:1405–1411.
Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










T erapeutics and Clinical Risk M anagement
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa l
Therapeutics and Clinical Risk Management is an international, peer-
reviewed journal of clinical therapeutics and risk management, focusing 
on concise rapid reporting of clinical studies in all therapeutic areas, 
outcomes, safety, and programs for the effective, safe, and sustained 
use of medicines. This journal is indexed on PubMed Central, CAS, 
EMBase, Scopus and the Elsevier Bibliographic databases. The 
manuscript management system is completely online and includes a 
very quick and fair peer-review system, which is all easy to use. Visit 
http://www.dovepress.com/testimonials.php to read real quotes from 
published authors.






44. Schoenfeld JD, Sher DJ, Norris CM Jr, et al. Salivary gland tumors 
treated with adjuvant intensity-modulated radiotherapy with or with-
out concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2012; 
82:308–314.
45. Atkinson JC, Wu AJ. Salivary gland dysfunction: causes, symptoms, 
treatment. J Am Dent Assoc. 1994;125:409–416.
46. Spielman AI. Gustducin and its role in taste. J Dent Res. 1998; 
77:539–544.
47. Pedersen AM, Bardow A, Jensen SB, Nauntofte B. Saliva and gastroin-
testinal functions of taste, mastication, swallowing and digestion. Oral 
Dis. 2002;8:117–129.
48. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. 
Candidal colonization and oral candidiasis in patients undergoing oral 
and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol 
Oral Radiol Endod. 1997;84:149–153.
49. Chen TY, Webster JH. Oral monilia study on patients with head and 
neck cancer during radiotherapy. Cancer . 1974;34:246–249.
50. Samaranayake LP, Lamey PJ. Oral candidosis: 1. clinicopathological 
aspects. Dent Update. 1988;15(6):227–228; 230–231.
51. Kuntz R, Allen M, Osburn J. Xerostomia. Int J Pharm Compd. 2000; 
4:1176–1177.
52. Almeida JP, Kowalski LP. Pilocarpine used to treat xerostomia in 
patients submitted to radioactive iodine therapy: a pilot study. Braz J 
Otorhinolaryngol . 2010;76(5):659–662.
53. Koseki M, Maki Y, Matsukubo T, Ohashi Y, Tsubota K. Salivary ﬂow 
and its relationship to oral signs and symptoms in patients with dry eyes. 
Oral Dis. 2004;10(2):75–80.
54. Tomiita M, Takei S, Kuwada N, et al. Efﬁcacy and safety of orally 
administered pilocarpine hydrochloride for patients with juvenile-onset 
Sjögren’s syndrome. Mod Rheumatol . 2010;20(5):486–490.
55. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treat-
ment of primary Sjögren syndrome: a systematic review. JAMA. 
2010;304(4):452–460.
56. Hendrickson RG, Morocco AP, Greenberg MI. Pilocarpine toxicity and 
the treatment of xerostomia. J Emerg Med. 2004;26(4):429–432.
57. Chambers MS, Jones CU, Biel MA, et al. Open-label, long-term safety 
study of cevimeline in the treatment of postirradiation xerostomia. Int 
J Radiat Oncol Biol Phys. 2007;69(5):1369–1376.
58. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment 
of postirradiation xerostomia in patients with head and neck cancer. Int 
J Radiat Oncol Biol Phys. 2007;68(4):1102–1109.
59. Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with 
the bile secretion-stimulant drug anethole trithione: a clinical trial. Am 
J Med Sci . 1999;318:146–151.
60. Bagheri H, Schmitt L, Berlan M, Montastruc JL. A comparative study 
of the effects of yohimbine and anetholtrithione on salivary secretion 
in depressed patients treated with psychotropic drugs. Eur J Clin 
Pharmacol . 1997;52:339–342.
61. Dyke S. Clinical management and review of Sjögren’s syndrome. Int 
J Pharm Compd. 2000;4:338–341.
62. Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. 
Acupuncture for pilocarpine-resistant xerostomia following radio-
therapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 
2001;50:353–357.
63. Sagar SM. Acupuncture as an evidence-based option for symptom con-
trol in cancer patients. Curr Treat Options Oncol . 2008;9:117–126.
64. Jedel E. Acupuncture in xerostomia – a systematic review. J Oral 
Rehabil . 2005;32:392–396.
65. Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of sali-
vary gland hypofunction and xerostomia induced by cancer therapies: 
management strategies and economic impact. Support Care Cancer . 
2010;18(8):1061–1079.
66. O’Sullivan EM, Higginson IJ. Clinical effectiveness and safety of 
acupuncture in the treatment of irradiation-induced xerostomia in 
patients with head and neck cancer: a systematic review. Acupunct 
Med. 2010;28:191–199.
67. Zhuang L, Yang Z, Zeng X, et al. The preventive and therapeutic effect 
of acupuncture for radiation-induced xerostomia in patients with head 
and neck cancer: a systematic review. Integr Cancer Ther. 2013;12: 
197–205.
68. Diaz-Arnold AM, Marek CA. The impact of saliva on patient care: 
a literature review. J Prosthet Dent. 2002;88:337–343.
69. Momm F, Volegova-Neher NJ, Schulte-Monting J, Guttenberger R. Differ-
ent saliva substitutes for treatment of xerostomia following radiotherapy. 
A prospective crossover study. Strahlenther Onkol . 2005;181:231–236.
70. Davies A. Clinically proved treatments for xerostomia were ignored. 
BMJ. 1998;316:1247.
Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  













































Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  










Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  













































Roberto Pinna,  
Clinical evaluation of a self-adhering material as desensitizing agent  
in xerostomic patients for head and neck cancer.,  
Tesi di Dottorato in Odontostomatologia preventiva,  
                  tudi di Sassari. 
 
77 

















1 Dept of Biomedical Sciences, University of Sassari, Italy 
2 Dept of Surgery, Microsurgery and Medicine, University of Sassari, Italy 
 




Objectives To investigate the clinical effectiveness over 12 weeks of Vertise Flow
TM
, a self-adhering 
composite, in dental hypersensitivity (DH).  
Material and Methods The study was conduced as a split-mouth randomized clinical trial. Vertise 
Flow
TM
 was compared to: 1) Universal Dentine Sealant, 2) Clearfil Protect Bond, and 3) Flor-Opal® 
Varnish. A total of 46 patients with 116 hypersensitive teeth were studied. Pain experience was generated 
by a cold stimulus and assessed using the Visual Analogue Scale (VAS) of pain. The response was 
recorded before the application of the materials (PRE-1), immediately after (POST-1), at 1 week (POST-
2), 2 weeks (POST-3) and 12 week controls (POST-4). Statistical differences in VAS were performed 
using the Kruskall-Wallis analysis at the different time-points (P <0.05), adjusting statistical significances 
for multiple comparisons (Bonferroni correction).  
Results All the materials showed any statistically significant differences at the baseline. After the 
application of each material, a VAS decrease was demonstrated at every post-control. VF showed 
significant hypersensitivity reduction in Post-1. Statistically significant relief was also observed in Post-2 
while no significant differences were detected in Post-3 and Post-4 . 
Conclusions After 12-week controls, there was no statistically significant hypersensitivity reduction 
using VF in respect to the other materials. On the other hand, any significant differences were detected in 
the decrease of the VAS irrespective of the desensitizing agent employed at the 12-week controls.  
Clinical Relevance The significant increase in VAS scores within the 12-weeks of environment 
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Dentine hypersensitivity (DH) is a common and painful syndrome, predominately located on the cervical 
part of the tooth buccal surface. DH has a wide prevalence rate  (3-98%) in the adult population, with a 
peak in 20–50 yy [1]. 
DH is characterized by a short and sharp sensation of pain arising from the tubular dentine exposure as a 
result of enamel loss and/or gingival root surface exposure due to attrition, abrasion, erosion, abfraction 
or gingival recession [2]. Any thermal, osmotic and mechanical stimuli induced by the application of 
tooth brushing, sweet and acid foods, hot or cold drinks may provoke pain referred to fluid shifts in the 
  po          a   ubu    w  h ac   a  o  of  h  pu p       , acco       o “B ä     öm’  hy  o y am c 
 h o y” [2-5].   
When reducing fluid movement by fully or partially occluding open dentine tubules, hypersensitivity 
could be diminished [6]. In fact most desensitizing agents have been designed to involve the dentine 
surface and occlude exposed tubules or penetrate the tubules, coating and sealing them [4,7-11]. 
Irrespective of the material used, the data demonstrated a decrease of sensitivity immediately after the 
application of materials in respect to the pre-treatment. However, the reported clinical outcome is quite 
variable in long term [7-11]. Data has been explained in the capacity of the material-dentine exposed 
surface to resist in face to interactions with saliva and oral ambient interferences. Moreover, differences 
in the efficacy were attributed to the different chemistries of the materials and application modalities 
required by the desensitizer itself [12-15]. 
Several different formulations of resin-based materials have being used in DH treatment. Four different 
kind can be summarized: 1) varnishes, usually with fluoride, creating a coat of calcium fluoride 
precipitates on the exposed surface and dentinal tubules [10,16-18]; 2) adhesive monomeric systems, with 
or without the etching phase, able to seal the exposed surface by a layer of interdiffusion in dentine and 
tubular resin plugs [12-14, 19]; 3) resin sealants and 4) flowable resin composites able to form covers on 
the dentine surface [20] which sealing capacity in the time is influenced by the resin composition and the 
coupling between filler and  matrix [21]. 
Recently, new self-adhering flowable resins have been developed. According to manufacturers, these 
resins bond to tooth surfaces due to the presence of acidic monomers thus avoiding the need of adhesives 
[21, 22].  One of these, Vertise Flow (VF) has been suggested by the manufacturer (Kerr Corporation, 
Orange, CA, USA), in different fields of restorative dentistry including DH therapy.  
VF consists of a new organic matrix of glycerol phosphate dimethacrylate (GPDM), proprietary 
methacrylate co-monomers, and nano-filler particles of barium glass, nano-sized colloidal-silica, nano-
sized ytterbium-fluoride [21].  
The clinical behaviour and morphological aspect of VF, used as desensitizing agent within 7 days of oral 
exposure was investigated [20]. After 7 days of oral fluids, VF showed a thick, irregular coat on the 
surface of exposed dentine with crystal-like filler particles in the tubules leading to reduction of the 
Visual Analogue Scale (VAS) of pain in hypersensitive teeth. At the same time, the SEM evidence of 
cracks and gaps in VF/dentine surfaces suggested a low bond strength that could be related to a hydrolytic 
instability due to the presence of leachable ions and the subsequent substitution of environmental water 
[20,21]. An increase of adhesion performance was reported in other studies using VF after a pre-etching 
procedure with phosphoric acid, or self-etch adhesive systems [23,24]. 
In light of the considerations above and of the scarcity of studies on self-adhering composites evaluated 
clinically as desensitizing agents, the aim of the present study was to investigate clinically, the 
effectiveness of VF in hypersensitivity teeth in comparison to three other different materials. 
The null hypotheses were: 
 there will be some statistical differences in DH using VF in comparison to the other desensitizing 
agents at the 12-week control;  
 VF will relieve DH at the 12-week treatment. 
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Materials and Methods 
 
Partecipants 
The study was designed as a split-mouth randomized clinical trial. The protocol and informed consent 
forms were approved by the ethics committee at the University of Sassari (n° 1000/CE). Subjects who 
had hypersensitive teeth were selected from an on-going program of evaluating desensitizing agents at the 
Dental Clinic of the University of Sassari, Italy.  
Two examiners selected patients complaining about hypersensitivity and who had reported this to the 
Department of Periodontology at the Dental Clinic. The medical and dental history of the patients was 
collected, and sensitive teeth were differentiated from other clinical conditions that frequently interfere 
with DH. To participate in the study, the subjects had to have two or three teeth that were hypersensitive 
to the stimulation with a blast of air.  
A    h   ubj c   w     ho ou h y   fo m   abou   h    u y’  pu po  ,    k , a   b   f   . A  o a  of 86 
patients with hypersensitive teeth were collected. The study inclusion/exclusion criteria were the 
following: 1) patients were considered suitable for the study if they had sensitive teeth showing abrasion, 
erosion or recession with the exposure of the cervical dentine; 2) teeth with subjective or objective 
evidence of carious lesions, pulpitis, restorations, premature contact, cracked enamel, active periapical 
infection, or which had received periodontal surgery or root-planning up to 6 months prior to the 
investigation were excluded from the study. Other exclusion criteria were professional desensitizing 
therapy during the previous 3 months, or use of desensitizing toothpaste in the last 6 weeks. Patients were 
also excluded if they were under significant medication that could have interfered with pain perception 
(e.g., antidepressants, anti-inflammatory drugs, sedatives, and muscle relaxants). As a consequence, the 
total study population included in the program consisted of 46 patients, 27 females and 19 males who 
were randomly selected from the total population of 74 subjects who had hypersensitive teeth. A total of 
116 teeth (52 incisors, 38 premolars, and 26 cuspidates) were included in the study.  
 
Clinical Procedure 
VF self adhering composite was compared to: Universal Dentin Sealant (UDS) (Ultradent Products Inc., 
South Jordan, UT, USA), a biocompatible, non-polymerizable, high molecular weight resin sealant in 
alcohol solvent, Clearfil Protect Bond (CPB), (Kuraray Noritake Dental, Osaka, Japan) a methacrilate-
based resin, self-etching adhesive system, and Flor-Opal® Varnish (FOV), (Ultradent Products Inc., 
South Jordan, UT, USA), a fluoride-based varnish (Tab. 1).  
A week before the experiment, patients received oral prophylaxis. Non-fluoride toothpaste (Biorepair, 
Coswell), soft toothbrush (Oral-B Sensitive Advantage, Procter & Gamble) and oral hygiene instructions 
were also provided in order to have standardized habits during the period of the study.  
In view of the treatment with the desensitizing agents, teeth were randomly assigned in to four groups 
(N=29 per group) (Fig. 1). The level of sensitivity experienced by each patient was considered as 
independent of the position of the hypersensitive tooth in the oral cavity 11]. The pain experience was 
assessed using a Visual Analogue Scores (VAS) graded from 1 to 10, according to the same procedure of 
a previous study [20]. The pain stimulus was given by one examiner with the same equipment yielding 
similar air pressure each time, while the other one performed the treatments. The subject's response was 
considered before the application of the material (PRE-1), immediately after (POST-1), after 1 week 
(POST- 2), 4 weeks (POST- 3) and 12 weeks (POST-4) of oral environment, the same operator carried 
out the sensitivity test. None of the participants failed to complete the study, and none of them reported 
any adverse reactions. 
 
Statistical Analysis 
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Shapiro-Wilk normality test was used to assess the normality distribution of the collected variables. 
Median and inter-quartile ranges were used as measures of central tendency and variability to describe 
quantitative variables. Statistical differences in the Visual Analogue Scale (VAS) values of VF, UDS, 
CPB and FOV were performed using the Kruskall-Wallis analysis at the different time-points, adjusting 
statistical significance for the multiple comparisons (Bonferroni correction). Statistical differences at the 
baseline VAS value and the other time-points were calculated performing the Mann–Whitney U test. 
Statistical analysis was carried out using IBM® SPSS® Statistics, Version 21.0 (IBM Corporation ©, 





The sample size based on the initial assumptions showed a statistical power higher than 80%. 
Table 2 shows the median VAS scores at the different time-points.  
At baseline (VAS score), no significant statistical differences were observed (p-value >0.05) among the 
groups  (Fig. 2). After the applications of the materials, statistical significant decrease of the VAS values 
was observed proceeding from Post-1 to Post-4 control.  
Teeth treated with VF showed lower VAS scores at Post-1 control when compared to UDS (p-value 
>0.001), CPB (p-value =0.001), and FOV (p-value >0.001) (Fig. 3), while at Post-2, a significant 
statistical reduction of the value was demonstrated in VF in comparison to UDS (p-value =0.001) and 
FOV (p-value =0.001) (Fig. 4). As far as the Post-3 and Post-4 controls, no significant differences were 
detected in VF efficiency in respect to any other materials (Fig. 5 and 6). Also, post-treatment values 
showed a significant decrease in the VAS score in all of the groups in comparison to the baseline values 





VAS has been accepted as a method to evaluate pain in DH and thus, the effectiveness of desensitizing 
agents in pain reduction. In clinical trials, the VAS value has been assessed thought different stimuli, 
among which the cold stimulation, via an air dental syringe, is largely accepted [8,9,11]. Thus, in the 
present study, a cold stimulus was used as measure of the VAS value both to select the study population 
of hypersensitive teeth as well as, in the reassessment of sensitivity prior the material applications, and in 
the post-treatment clinical outcomes.  
A 12-week evaluation was kept in consideration due to the fact that significant differences among the 
desensitizer effects may appear in long-term estimation of the agents [8,9,11]. Factors involved in the 
efficiency of the desensitizers are first of all the intrinsic material performance, strictly related to the 
different formulation [16] and the active ingredient of the materials [9,19]. The leach of ions by resins 
may affect the sealing capacity of the desensitizing agents in oral fluids [25,26]. Another factor is the 
stability of the tubular occlusions produced by the agents, which is related to the composition of the 
blocks [17] finally derived by the interaction of the material components with the oral fluids [17,27].  
In view of the consideration above, the efficiency of VF, which seal was questionable after 7 days of in 
vivo evaluation [20], was compared to other resin-based materials, testing the seal within 12-week 
treatment controls. VF was matched to 1) UDS resin sealant as the sealing performances of resin flow 
composites may be comparable to those of resin-based sealants, as in vivo as well as in vitro [28-30]; 2) 
PB    f   ch    a h       y   m a   FOV  a    h  o a       h  VF’           za  o   ff c     a  a    of 
efficiency of known classes of resins just reported in DH treatment [13]. 
Data obtained in this study demonstrated that of the VAS value was reduced after the application of VF 
and the other desensitizing agents when compared to the baseline. However, different responses could be 
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observed in the post-treatment controls as a consequence of the material composition and interaction 
capacity in dentine under oral environment (Fig. 7). 
Compared with the baseline, VF showed the ability to significantly reduce the sensitivity immediately 
after the application, however lowering its efficiency within the 12-week post-treatments, as a possible 
loss of the resin sealing in dentine under oral fluids exposure.  
The significant decrease of the VAS in POST-1 may be attributed to the intimate particles rich layer 
formed by the self-adhering composite on the dentine [20]. Under SEM, VF layer covered the exposed 
surface of dentine leading to tubular seals and reduction of sensitivity. The particle layer might establish a 
high chemical and physical bonding in dentine due to the acidic monomer composition of the self-
adhering composite and the present of specific ions in the mass, along with Si, Yt and F. The acidic 
monomer in VF might raise the concentration of Ca and P from the dentine to a point where it exceeded 
 h  p o uc ’   o ub    y co   a    [31],  hu  allowing for the subsequent precipitation of Ca-P complexes 
[28] with micromechanical interactions in tubular dentine [20]. The reduction of the tubular orifices can 
explain the significant decrease of DH, as any substance that causes a decrease of tubular radius is able to 
reduce clinical symptoms of DH by reducing fluid conductance [32].  
It is like, however, that the same chemical components of the composite mass might be responsible for 
the deterioration of the physico-mechanical properties of the resin cover within the 12-week controls. 
Indeed, it has been stated that the resin-based materials absorb water in an aqueous environment mainly 
due to a hydrolytic breakdown of the bond between the silane and filler particles, filler-matrix debonding 
or even hydrolytic degradation of the fillers [33]. A hydrolytic breakdown has been supposed in VF in 
water mostly related to the presence of leachable ions of Si, Yt, F, and Ba [21]. The high presence of Si, 
Yt, F, and Ba, identified in VF by the EDX [20], may have allowed the permeation of water molecules 
into the spaces previously occupied by these ions [33, 34]. This process may explain a possible reduction 
of the strength of resin–filler interface, a weakening of the mechanical properties, and the chemical bond 
of VF in dentine.  
UDS revealed Ca, Cl, and Si as the highest ions in the resin matrix, also containing Al ion peaks [20]. 
Clinically, the behaviour of the resin sealant was different to that of the self-adhesive composite. In 
comparison to VF, UDS produced a slowly but continue decrease of the VAS showing the higher most 
stable desensitizing effect at the 12-week controls. Results may be related to the different composition 
and filler treatment in UDS in respect to VF [20], leading to a filler-polymer bond probably less 
attackable by water degradation under oral exposure. Moreover, the different behavior of UDS in respect 
to VF, may suggest that the 12-weeks of oral environment would be essential for the sealant expression. 
In the case of CPB, the presence of Si, P, Al and F ions are explained in the acidic methacrylate 
composition of the self-etching adhesive, which is also enriched by polysiloxane-encapsulated sodium 
fluoride fillers as a source of fluorine ions release [35]. Clinically, CPB showed a significant decrease of 
the VAS in POST-1, that remained stable within the 12-week controls. The significant decrease in DH 
immediately after CPB application may be related to the high bonding capacity in tubular dentine. The 
strong adhesion in dentine may be the result of the 1) chemical bonding of the acidic functional monomer 
MDP contained in the CPB allowing for a ionic interaction to the calcium in dentine [36], and 2) 
micromechanical bonding due to the fluoro-alumino-silicate glasses in the filler capable to react with the 
acidic monomer following a typical glass-ionomer acid–base reaction [35]. Still, the reduction in 
efficiency observed within the 12-week controls may be explained in the incapacity of the resin adhesive 
to resist in face to the fluid exposure unless a composite cover is performed [37]. 
FOV, a resin varnish rich in Na and F, and Si and P traces [20], clinically demonstrated low efficiency in 
DH when compared to the other materials. FOV showed a higher VAS score after the 12-week control.  
The initial reduction of VAS value by FOV may be explained by the presence of a cover of varnish on 
dentine with precipitation of crystallites of calcium fluoride or phosphate containing calcium fluoride in 
the opening of the tubules [7,17]. This mechanism of covering, previous observed in vivo [20], is able to 
reduce the tubular apertures in exposed dentine with a decrease of tubular fluid conductance and DH [32], 
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as was observed in POST-1. However, the progressive decline in effectiveness demonstrated the inability 






As a result of this investigation, all the materials tested produced a reduction of dentine permeability. 
However, after 12-week controls, there was no significant statistical difference in the decrease of the 
VAS irrespective of the desensitizing agent employed.  
Even if VF produced a significant reduction of DH in Post-1, the chemical components of the resin, 
mostly related to the presence of leachable species, may have interfered with the stability of the seal 
under oral environment exposure. A significant increase was observed in scores within the 12-week 
controls as a possible consequence of deterioration of the physical-mechanical properties of the resin 
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Fig. 1 - Summary of the experimental design to collect hypersensitivity teeth to test the efficiency of 




Fig. 2 - Pairwise comparisons between VAS values in Pre-1. 
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Fig. 4 - Pairwise comparisons between VAS values in Post-2. 
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Fig. 5 - Pairwise comparisons between VAS values in Post-3. 
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Aim: To evaluate the desensitizing capacity of four different materials to treat dentine hypersensitivity 
(DH) in xerostomic patients due to radiotherapy for head and neck cancer. 
Methods: A total of 24 patients underwent to radiotherapy were selected for the study. The study was 
conducted as a split-mouth randomized clinical trial, comparing: 1) Vertise FlowTM (VF), 2) Universal 
Dentine Sealant (UDS), 3) Clearfil Protect Bond (CPB), and 4) Flor-Opal® Varnish (FOV). Basal and 
stimulated salivary flow was recorded for each patient according to European classification criteria 
(1993). The pain experience was generated by a cold stimulus directly to sensitive tooth surface and 
assessed using the Visual Analogue Scale (VAS). The response was recorded before the application of the 
materials (PRE-1), immediately after (POST-1), at 1 week (POST-2), 4 weeks (POST-3) and 12 week 
controls (POST-4).  
Results: The number of patients meeting the inclusion criteria was eight. The mean basal salivary flow 
rate was 0.24 ml/min (minimum 0.06 – maximum 0.42), while the stimulated rate was 0.54 ml/min 
(minimum 0.29 – maximum 0.86). . At POST-4, UDS showed the best desensitizing capacity  in 
comparison  to the other materials agents, while FOV was the less effective in the reduction of VAS 
values.  
Conclusion: As a result of this investigation, all the materials tested produced a reduction of dentine 
hypersensitivity. However, after 12-week controls, there was no significant difference in the decrease of 
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X  o  om a    a    m u     o    c  b   h   ubj c      ymp om  of “  y mou h” f  qu    y          f om a 
lack of saliva (1,2). Most patients with head and neck cancer (HNC) usually receive radiotherapy as a part 
of their cancer treatment. As a radiation dose to destroy malignant cells, HNC patients routinely have a 
total of 50-70 Gythat very often leads to the onset of salivary gland hypofunction and chronic xerostomia 
(3). In fact, during and following the full course of radiotherapy, xerostomia and hyposalivation rise as 
the most common complications and occur to some degree in up to 100% of patients, severely impairing 
their quality of life (QOL) (4-8).  
The salivary glands are superficially located compared to most head and neck tumors, and thus, the 
ionizing radiation has to pass through the salivary glands to effectively treat the tumor (9).The reduced 
secretion rates and the alteration in the quality of saliva in irradiated patients are due to irreversible 
fibrosis and atrophy of the gland parenchyma (11), as well as damage to extra glandular blood vessels or 
nerve structures (12).  
Saliva plays an essential role for the health condition of the oral cavity (11). Thanks to the properties to 
humidify and lubricate the soft and hard tissue, saliva plays protective effects of the tissues, among which 
the  preventing of mechanical damage. As regard to the tooth structural integrity, the buffering effect of 
the saliva is very important in the control of demineralization/remineralization process (11-13). 
Physiologically saliva is supersaturated with respect to the tooth mineral content. Among the inorganic 
components, bicarbonate is related to saliva buffering capacity, while calcium, fluoride and phosphate are 
necessary for remineralization allowing for the maintenance of tooth mineral integrity (14). 
As a consequence of a reduction in the rate of saliva flow, which is correlated to the amount of radiation 
given to the patients, oral complications will occur (15). An increase of  dentine hypersensitivity (DH) 
may represent one of the most common manifestations that affects patients after radiotherapy (16-19).  
DH is characterized by a short and sharp sensation of pain arising from the tubular dentine exposure as a 
result of enamel loss and/or gingival root surface exposure due to attrition, abrasion, erosion, abfraction 
or gingival recession (20). Any thermal, osmotic and mechanical stimuli induced by the application of 
tooth brushing, sweet and acid foods, hot or cold drinks may provoke pain referred to fluid shifts in the 
  po          a   ubu    w  h ac   a  o  of  h  pu p       , acco       o “B ä     öm’  hy  o y am c 
 h o y” (2-23). Therefore, the occlusion of the tubules by different materials may reduce the fluid 
movement inside the dentinal tubules and the clinical symptoms of DH (24). When reducing fluid 
movement by fully or partially occluding open dentine tubules, hypersensitivity could be diminished (25). 
Consequently, most desensitizing agents have been designed to ?? cover the dentine surface with 
occlusion of the  exposed tubules or penetration in the tubules, coating and sealing them (22,26-30).  
However, the efficacy of desensitizing agents is quite variable in long term, as reported in our previous 
studies and other clinical outcomes conditions (26 – 31.  The desensitizing capacity has been correlated to 
the ability of the material to resist in front of the interactions of saliva and other oral ambient 
interferences (31). 
In light of the considerations above and of the scarcity of clinical studies on the effectiveness of 
desensitizing agents in xerostomic patients due to radiotherapy for HNC, the aim of the present study was 
to investigate clinically, the efficacy of four different kind of materials in the relief of DH. 
The null hypotheses were: 
 There will be no statistical differences in DH reduction among the desensitizing agents at the 12-
week control, 
 There will be no statistical differences in effectiveness of desensitizing agents among xerostomic 
patients and patients with normal salivary flow. 
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Materials and Methods  
 
Partecipants 
The study was designed as a split-mouth randomized clinical trial. The protocol and informed consent 
forms were approved by the ethics committee at the University of Sassari (n° 1000/CE). Radio-
therapeutic patients who had hypersensitive teeth were selected from an on-going program of evaluating 
desensitizing agents at the Dental Clinic of the University of Sassari, Italy.  
During 2013, a total of 48 patients were visited at the Department of Radiology. 24 patients, which 
needed radiotherapy for HNC were collected. These groups of patients were subjected to a dental check-
up with eventual teeth treatments, during and after the radiotherapy. Few months later the end of the 
radio-exposition, 8 patients began to complain HD. 
To pa   c pa       h    u y a    h   ubj c   w     ho ou h y   fo m   abou   h    u y’  pu po  ,    k , a   
benefits. 
The study inclusion criteria were the following: 
 A relative good general health status; 
 A clinical reduction of salivary flow; 
 Two or three teeth that were hypersensitive to the stimulation with a blast of air. 
In addition, patients were considered suitable for the study if they had sensitive teeth showing abrasion, 
erosion or recession with the exposure of the cervical dentine. 
The study exclusion criteria were:  
 teeth with subjective or objective evidence of carious lesions, pulpitis, restorations, premature 
contact, cracked enamel, active periapical infection; 
 received periodontal surgery or root-planning up to 6 months prior to the investigation; 
 professional desensitizing therapy during the previous 3 months 
 use of desensitizing toothpaste in the last 6 weeks. 
Patients were also excluded if they were under significant medication that could have interfered with pain 





All salivary assessments were performed in the absence of acute sialadenitis. The flow rate was 
determined in every person according to the method described by Sreebny (32). Saliva was collected in a 
standardised manner. Patients were instructed not to eat, drink, or smoke for 90 minutes before the 
sialometric assessment. All assessments were performed at a fixed time of the day, between 10 am and 1 
pm, in order to minimise fluctuations related to a circadian rhythm of salivary secretion and composition. 
All assessments were performed by the same observer. Whole saliva was collected in pre-weighed plastic 
tubes using an electronic scale. 
Unstimulated salivary secretions were collected for 5 min with the patient seated in an upright position 
and with the tilted head. When possible the tongue, cheeks and lips movements were limited during the 
procedure. At the end of the collection period, the patient had to expectorate saliva into the test-
tube.Stimulated whole saliva was collected asking to patients to chew a small block of paraffin wax or 
chewing gum. All the saliva secreted for 5 min was then collected in the test-tube.Measuring vessels were 
weighed after each collection using an electronic scale, and salivary flow rate was expressed in ml/min, 
which is nearly equivalent to g/min (33). A secretion rate < 0.1-0.2 ml/min for unstimulated flow and < 
0.5-0.7 ml/min for stimulated flow was considered as an objective sign of hyposalivation. 
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Assessment of hypersensitivity and desensitizing agents application. 
A week before the experiment, patients received oral prophylaxis. Non-fluoride toothpaste (Biorepair, 
Coswell), soft toothbrush (Oral-B Sensitive Advantage, Procter & Gamble) and oral hygiene instructions 
were also provided in order to have standardized habits during the period of the study.  The level of 
sensitivity experienced by each patient was considered as independent of the position of the 
hypersensitive tooth in the oral cavity (30). The pain experience was assessed using a Visual Analogue 
Scores (VAS) according the methodology described in the previous studies (34) 
The following dental materials were used following manufacture instructions: Vertise Flow
TM 
(VF) (Kerr 
Corporation, Orange, CA, USA), a self-adhering composite; Universal Dentin Sealant (UDS) (Ultradent 
Products Inc., South Jordan, UT, USA), a biocompatible, non-polymerizable, high molecular weight resin 
sealant in alcohol solvent; Clearfil Protect Bond (CPB), (Kuraray Noritake Dental, Osaka, Japan) a 
methacrilate-based resin, self-etching adhesive system, and Flor-Opal® Varnish (FOV), (Ultradent 
Products Inc., South Jordan, UT, USA), a fluoride-based varnish (Tab. 1).  
All 8 patients were considered eligible and agreed to take part in the study. In view of the treatment with 
the desensitizing agents, teeth were randomly assigned into four groups (N= per group) (Fig. 1). None of 
the participants failed to complete the study neither reported any adverse reactions. 
 
Statistical Analysis 
Shapiro-Wilk normality test was used to assess the normality distribution of the collected variables. 
Median and inter-quartile range were used as measures of central tendency and variability to describe 
quantitative variables. Statistical differences between Visual Analogue Scale (VAS) values of Vertise 
FlowTM, Universal Dentine Sealant, Clearfil Protect Bond and Flor-Opal® Varnish were evaluated 
performing Kruskall-Wallis analysis at different time points, adjusting statistical significance for the 
multiple comparisons (Bonferroni correction). Statistical differences between baseline VAS values and 
those obtained at other time-points were calculated performing the Mann–Whitney U test. Statistical 
analysis was carried out using IBM® SPSS® Statistics, Version 21.0 (IBM Corporation ©, Armonk, NY, 
USA) and STATA®13 (StataCorp, College Station, TX, USA). 
Statistical differences between VAS values of xerostomic group and  normo-salivation group were 
calculated performing the Mann–Whitney U test. Statistical analysis was carried out using STATA®13 





The mean basal salivary flow rate was 0.24 ml/min (minimum 0.06 – maximum 0.42) while the 
stimulated rate was of 0.54 ml/min (minimum 0.29 – maximum 0.86). 
The median VAS scores at different time-points is shown in Table 1. No statistically significant 
differences between the baseline VAS scores were observed (p-value >0.05) (Fig. 2). Following the 
exposure to the materials, a statistically significant VAS decreases was observed from Post-1 to Post-3; 
no statistical differences were detected in the final point. Teeth treated with Vertise FlowTM  and 
Universal Dentine Sealant showed lower VAS scores at Post-1 in in comparison to those treated with 
Clearfil Protect Bond (p-value <0.0001), and Flor-Opal® Varnish (p-value <0.0001) (Fig. 3). On the 
other hand, statistically significant lower VAS values were showed for Vertise FlowTM  and Universal 
Dentine Sealant in Post-2 when compared to Flor-Opal® Varnish (p-value =0.0002 and p-value<0.0001, 
respectively) (Fig. 4). Significantly higher VAS values were reported in regard to Flor-Opal® Varnish, 
Universal Dentine Sealant (p-value =0.0003) and Clearfil Protect Bond (p-value =0.0002) (Figure 5). 
Conversely, no significant differences were detected at Post-4 (Fig. 6). In the case of Universal Dentine 
Sealant and  Clearfil Protect Bond, the baseline, Pre-1, and the post-treatment values Post-4 showed 
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     f ca   VA   co     c  a   ,  Th   wa  ’      h  ca   of V       F owTM  a   F o -Opal® Varnish 
(Tab. 2). 
Moreover, no statistically significant differences (p-value >0.05) were detected at the baseline VAS when 
the xerostomic group was compared to the healthy (Tab. 3). Statistically lower VAS values were showed 
in the normo-salivation group treated with Vertise FlowTM , Clearfil Protect Bond and Flor-Opal® 




DH arises from the tubular dentine exposure and represent a common, painful and subjective symptom 
that is difficult to quantify (35-37). Nevertheless, the VAS scale is an accepted method of pain 
measurement (38). Sealing the dentine tubules by the use of adhesive materials and varnishes has been 
considered the primary choice in DH treatment, according to Hydrodynamic Theory (39-44).  
 Adhesive materials which contain acidic monomers as part of their chemicall formula, might raise the 
co c    a  o  of Ca a   P f om  h           o a po    wh         c       h  p o uc ’   o ub    y co   a    
(45). In this way, precipitation of Ca-P complexes will be allowed  at the dentine surface (46) with 
consequent micromechanical interactions in tubules (47). The reduction of tubular orifices can explain the 
significant decrease of DH, as any substance that causes a decrease of tubular radius is able to reduce 
clinical symptoms of DH by reducing fluid conductance (47). 
The therapeutic mechanism of varnish in DH is caused by the reaction of NaF or Oxalates at the surface 
of dentine (?) that results in the precipitations of insoluble calcium crystallites at the opening of the 
tubules (26,42-44,48-50). This mechanism, observed both in vitro (51, 52) and  in vivo (34), is able to 
reduce the tubular apertures in exposed dentine with a decrease of tubular fluid conductance and DH (47). 
However, the efficacy of different desensitizers is still a concern. This is because significant differences 
among the materials could appear in long-term estimation of the agents (30,57,58),  Conversely, most of 
the clinical data were reported at short-term  evaluation (53-56) and yielded poor results (53-56). 
Consequently, it is no gold standard for the treatment of DH available today (59). Factors involved in the 
efficiency of the desensitizers are particularly related to the intrinsic material performance, strictly 
connected to the own formulation of the agent (60), as well as the active ingredient of the material 
(28,61). Moreover, in this view the stability of tubular occlusions must be considered, , which has been 
related to the composition of the blocks [48] finally derived by the interaction of the material components 
within the oral environment (28,62). 
Due to the lack of information about DH in radiotherapeutic xerostomia, this study was undertaken to 
investigate the effectiveness of four different desensitizing agents with the purpose to identify the 
material of choice . Also, the response of the hyposalivary group was compared to a group of 
normosalivary patients in order to understand differences between the two groups. All the eight patients 
(101 teeth) completed the 12-week evaluation study. Data obtained in demonstrated that of the VAS value 
was significantly reduced after the application of all the materials (Tab 1). This is really evident for VF 
and CPB, both showing an overall specular behaviour (Fig. 7). It could be speculated that the reduced 
presence of saliva, as found among the patients, was a determinant factor in this result. In fact, one of the 
major factor in the reduction of the adhesive bond in dentine is the hydrolysis of the adhesive material 
within water exposure (63). In an oral environment with low saliva volume these materials could be able 
to increase their performance.At the same time, it could be speculated that the clinical condition of 
xerostomia, may lower the bonding in time.. The occlusal stress, thermal stress and chemical attack by 
acid and enzymes may affect the adhesive sealing, compromising the integrity of the adhesive restoration 
(63). Consequently, comparing the data with those obtained in our previous evaluation (31), both the 
materials may have behaved overall in a less stable manner (Fig. 7). However, after 12-week controls, 
both VF and CPB showed a dramatically decrease of performance with reduction of the VAS scores in a 
similar manner to those observed at PRE-1 (Fig. 7).  
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As reported in the previous study (31) (Fig. 7), UDS produced a slow but continue decrease of the VAS 
scores (Fig. 7). The results may be related to the proper composition of UDS and the presence of fillers in 
the resin mass of  [34]. Unlike it  was previously reported, at 12-week controls UDS VAS decreases 
showing similar values to those noted at  PRE-1, similarly to VF and CPB (Fig. 7).  
As regard to FOV, it  demonstrated the lower efficiency in DH when compared to the other materials 
(Fig. 7). As previous observed in vivo [34], the reduction of VAS scores in FOV is due to precipitation of 
crystallites of calcium fluoride or phosphate containing calcium fluoride in the opening of the tubules. In 
this study, FOV showed the higher VAS scores after the 12-week control. It could be speculated that the 
reduction of saliva might  have affected  the performance of the varnish as in the case of UDS and FOV. 
In light of these data, the first null hypothesis has been accepted: after 12-week controls there is no 
statistically significant difference among all desensitizers (Tab 1). Conversely,  the second null 
hypo h     wa    j c      c p      h  ca   of  D , wh ch     ’   how a            a     ca  y      f ca   






As a result of this investigation, in xerostomic patients all materials tested produced a significant 
reduction in the dentine sensibility when compared to the baseline. All agents were effective immediately 
after the application, whereas a significant increase of DH was observed within the 12-week controls as a 
possible consequence of deterioration of the physical-mechanical properties of the materials. The lack of 
information about the DH treatment in radiotherapeutic xerostomic patients ensure that further studies 
should be carried out. Anyway, within the limits of this study, it is not possible to indicate a material as a 
gold standard of care, as there are no significant differences in efficacy among the desensitizing agents in 
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Fig. 1.Summary of the experimental design to collect hypersensitivity teeth to test the efficiency of 




Statistical significance level (Bonferroni correction): p-value <0.008. 
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*Statistical significance level (Bonferroni correction): p-value <0.008. 
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Fig. 7. Trend of VAS Scores. 
 
